Next Article in Journal
Puerariae lobatae Radix Alleviates Pre-Eclampsia by Remodeling Gut Microbiota and Protecting the Gut and Placental Barriers
Next Article in Special Issue
Caffeine and the Risk of Diabetic Retinopathy in Type 2 Diabetes Mellitus: Findings from Clinical and Experimental Studies
Previous Article in Journal
Assessing Consumer Willingness to Pay for Nutritional Information Using a Dietary App
Previous Article in Special Issue
The Relationship between Nutrient Intake and Cataracts in the Older Adult Population of Korea
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Systematic Review

Dietary Intake and Diabetic Retinopathy: A Systematic Review of the Literature

1
Singapore Eye Research Institute, Singapore National Eye Centre, Singapore 169856, Singapore
2
Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore 308232, Singapore
3
SERI-NTU Advanced Ocular Engineering (STANCE), Singapore 639798, Singapore
4
School of Chemistry, Chemical Engineering and Biotechnology, Nanyang Technological University, Singapore 639798, Singapore
5
Ophthalmology and Visual Sciences Academic Clinical Program, Duke-NUS Medical School, National University of Singapore, Singapore 169857, Singapore
*
Author to whom correspondence should be addressed.
These authors have contributed equally to this work and share the first authorship.
Nutrients 2022, 14(23), 5021; https://doi.org/10.3390/nu14235021
Submission received: 6 October 2022 / Revised: 18 November 2022 / Accepted: 22 November 2022 / Published: 25 November 2022
(This article belongs to the Special Issue Effects of Nutrients on Eye Health)

Abstract

:
Diabetic retinopathy (DR) is a common microvascular complication of diabetes mellitus. The evidence connecting dietary intake and DR is emerging, but uncertain. We conducted a systematic review to comprehensively summarize the current understanding of the associations between dietary consumption, DR and diabetic macular edema (DME). We systematically searched PubMed, Embase, Medline, and the Cochrane Central Register of Controlled Trials between January 1967 to May 2022 for all studies investigating the effect of diet on DR and DME. Of the 4962 articles initially identified, 54 relevant articles were retained. Our review found that higher intakes of fruits, vegetables, dietary fibers, fish, a Mediterranean diet, oleic acid, and tea were found to have a protective effect against DR. Conversely, high intakes of diet soda, caloric intake, rice, and choline were associated with a higher risk of DR. No association was seen between vitamin C, riboflavin, vitamin D, and milk and DR. Only one study in our review assessed dietary intake and DME and found a risk of high sodium intake for DME progression. Therefore, the general recommendation for nutritional counseling to manage diabetes may be beneficial to prevent DR risk, but prospective studies in diverse diabetic populations are needed to confirm our findings and expand clinical guidelines for DR management.

1. Introduction

Diabetic retinopathy (DR; Figure 1) is a leading cause of vision loss globally. From 1990–2020, DR ranked as the fifth most common cause of preventable blindness and the fifth most common cause of moderate-to-worse visual impairment [1]. Approximately one in three people with diabetes mellitus suffer from DR and a third of these are afflicted with vision-threatening retinopathy, defined as severe non-proliferative DR or proliferative DR (PDR) or the presence of diabetic macular edema (DME) [2]. According to the Global Burden of Disease study, the age-standardized prevalence of blindness caused by DR showed a substantial increase between 1990 and 2020 in many regions of Asia [3], sub-Saharan Africa, as well as high-income North America [1]. The number of people with diabetes is estimated to be around 600 million by 2040 [4]. With this projected rise in the diabetic population coupled with increased life expectancy, the number of people with visual impairment due to DR is expected to rise worldwide [5]. Of concern is that DR is the most frequent cause of visual impairment among working-age individuals [1], and vision loss from DR places a considerable burden on patients’ quality of life (QoL) [6]. Therefore, finding effective ways to prevent or control the progression of DR is of critical importance.
Appropriate nutrition is an essential component of diabetes management [7]. Even though dietary guidelines for managing diabetes and prediabetes have been proposed [7], their role in the development and progression of DR has not been clearly defined. Nutrition counseling that works toward improving or controlling glycemic targets, attaining weight management goals, and enhancing cardiovascular risk factors (e.g., blood pressure, lipids, etc.) may benefit persons with DR. Studies show a favorable association between dietary changes and a reduction in the risk of DR [8,9]. Thus, adopting nutritional therapy in earlier stages may prevent the development and progression of DR and consequently help to reduce the treatment burden of this disease [10]. However, the risk factors for diabetes such as age, gender, and body mass index may not be necessarily risk factors for the development of DR. [11] Thus, the impact of diet modification on diabetes and that on DR may also differ.
Systematic reviews on the impact of diet on DR have been conducted [12,13,14,15,16]. Studies have recommended that the diet plays an important role in modifying the risk of DR by showing evidence of a protective effect of the Mediterranean diet, high fruit, vegetable, and fish intake, along with reduced calorie consumption, against the development of DR [12,13,15]. However, most of these dietary reviews on DR have focused on a specific food, nutrient, or dietary pattern [12,13,14]. Nevertheless, very few systematic reviews comprehensively assessed the entire spectrum of dietary components but are not very recent [15,16]. Several recent introductions of new dietary factors, i.e., selenium [17], vitamin B6 [18], vitamin B2 [17], choline [19], rice [20], cheese, wholemeal bread [21] and diet soda [22,23], with their influence on DR, are not included in previous comprehensive systematic reviews. For instance, two recent observational studies have highlighted diet soda as a risk factor for DR [22,23]. Additionally, more studies sharing information on the effect of already known dietary factors on DR are also available, thus adding more valuable knowledge to the nutritional impact on DR. For example, newly added observational studies showing the protective effect of tea [24] and Mediterranean food [25] on DR support a similar finding in a previous systematic review [15]. In contrast, the protective effect of the consumption of coffee [26], shown by a new observational study, was not seen in the previous systematic review [16,27]. Lastly, DME is a vision-threatening manifestation of DR, more commonly seen in severe stages of DR [28], and the association between diet and DME has not been reported in previous reviews.
In the present systematic review, we wanted to comprehensively summarize the current understanding of the associations between dietary components, DR and diabetic macular edema (DME).

2. Methods

2.1. Literature Search

Using the PRISMA checklist (Supplementary Table S1 [29]; Figure 2), we conducted a systematic review of all studies published in peer-reviewed journals with no language restrictions. We retrieved articles from Embase, PubMed, Medline, and the Cochrane Central Register of Controlled Trials with a date range from January 1967 to May 2022. We systematically searched the database by combining the following keywords: diet OR dietary intake OR vitamins OR antioxidants OR nutrients OR fruits OR vegetables OR alcohol OR milk OR tea OR coffee OR carbohydrates OR fatty acid OR proteins AND diabetic retinopathy OR diabetic macular edema.

2.2. Study Selection

Our search methodology identified 5367 titles that were screened by ZY and systematically excluded if they did not meet predefined inclusion criteria. The exclusion was performed independently by ZY and vetted by JS, and uncertainty was clarified by JC. The reference list of those articles fulfilling the eligibility criteria was also verified for further relevant studies.

2.3. Inclusion Criteria

According to the PRISMA guidelines, a PICOS (participants, intervention, comparability, outcomes, study design) framework was used to formulate the eligibility criteria.
  • Participants—Studies including human subjects with type1, type 2 diabetic mellitus, or both.
  • Study design—It included prospective, case–control, cross-sectional, and randomized controlled trials (RCTs).
  • Interventions or exposure—Studies that evaluated dietary intake using tools such as validated food frequency questionnaires, 24 h dietary recall, dietary history, or general interviewer-administered questionnaires. Dietary intake components included specific food, beverages, micronutrients, macronutrients, and dietary patterns (Figure 3).
  • Outcomes—It included prevalence, incidence, or progression of DR with or without DME. Studies that assessed DR outcomes by fundus photography, fundus examination using a direct or indirect ophthalmoscope, and fundus fluorescein angiography were accepted. Different scales for grading the severity of DR such as the Early Treatment Diabetic Retinopathy Study (ETDRS) and the International Classification system of DR were also accepted. The ETDRS is based on seven field stereophotographs, classifying DR from level 10 (absence of retinopathy) to level 85 (vitreous hemorrhage or retinal detachment involving macula). Conversely, the International Classification System grade cases into the categories of: no apparent retinopathy, mild, moderate, and severe non-proliferative retinopathy and final-stage proliferative diabetic retinopathy [30].

2.4. Exclusion Criteria

  • Animal studies, in vivo/in vitro studies and reviews.
  • Studies that included the non-diabetic, pre-diabetic, or impaired glucose intolerance participants, or patients with special types of diabetes such as gestational diabetes.
  • Studies with insufficient data, such as lack of exposure/outcome definitions or absence of statistical analysis which did not enable us to make conclusions.
  • Studies that measured only biomarkers in serum, blood, or urine with no relation to dietary intake.
  • Studies including intake in the form of supplements containing multiple different types of nutrients.
  • Studies describing outcomes using abnormal retinal changes, microvascular complications, or visual acuity but not defined in the form of DR severity.

2.5. Data Extraction

Data on the name of the first author, year, type of study, sample size, diabetes type, and participant’s age were extracted for each included study. Data extraction also included the components of dietary intake, method of assessment of dietary intake, DR outcome, DR diagnosis and its classification, confounders adjustment, statistical analysis, and summary of key findings. The ZY author performed the data extraction which was vetted by the JS author, and the JC author clarified uncertainty.

2.6. Study Quality Evaluation

The modified version of the Newcastle–Ottawa Scale (NOS; Figure 4) was used to evaluate the quality of observational studies [31]. In brief, the NOS is a scoring system whereby a maximum of 9 stars can be awarded to each study based upon three main criteria [32]:
  • Selection of participants (maximum of 4 stars).
  • Comparability (maximum of 2 stars).
  • Exposure (for prospective or cross-sectional designs) or outcome (for case–control designs) (maximum of 3 stars).
Studies were awarded an additional star if they incorporated validated methods to assess dietary intake like validated food frequency questionnaires (FFQs), 24 h dietary recalls, 3-day food records, or serum biomarker levels. Studies were categorized as low in quality when awarded <4 stars, medium for 5–7 stars, and high for >8 stars.
We applied the Cochrane Collaboration Risk of Bias tool to assess the bias risk in interventional studies, i.e., randomized controlled trials. Briefly, a study was considered to have an overall low risk of bias when all key criteria were graded as having low bias risk; overall medium bias risk when all key criteria were graded to have low or unclear bias risk; and overall high bias risk when one or more key criteria were graded to have a high bias risk [33].

3. Results

3.1. Description of Studies

We selected 54 papers from 4962 screened titles that met the requirements of our inclusion. (Figure 2). It included 3 interventional, 17 prospective, 29 cross-sectional, and 5 case–control studies.

3.2. Measurement of Exposures and Outcomes

Most observational studies measured the dietary intake using standard dietary methods such as 24 h recall (n = 4) [20,34,35], food frequency questionnaires (FFQ) (n = 23) [12,18,36,37,38,39,40,41,42,43,44,45,46,47,48,49,50], or 3-day food records (n = 3) [17,51,52]. A general-based interviewer-administered questionnaire was administered in 20 observational studies, and only one study evaluated dietary sodium intake from urinary excretion levels. Most of the studies assessed DR outcomes through fundus photograph (n = 30), 13 studies did through ophthalmology examination, or 5 studies from medical, clinical or hospital records, and 4 studies used a combination of photograph and examination (Table 1).

3.3. Methodological Quality

Of 51 observational studies, the majority had high NOS scores, with 37 classified as “high quality” (≥8 stars) and 14 classified as “moderate quality” (5–7 stars). Of the 3 interventional studies, 2 and 1 had a high risk and medium risk of bias, respectively (Table 1).

3.4. Relationship between Intake of Micronutrients to Diabetic Retinopathy

3.4.1. Antioxidants

The association between carotenoids (n = 6), vitamin C (n = 5), Vitamin E (n = 6), riboflavin (n = 1), and selenium (n = 1) with DR is reflected in Table 2.

Carotenoids

Tanaka and associates conducted a prospective study, finding that carotenoid intake was associated with reduced incident DR using a multivariate cox regression analysis of (Q4 [8.4 mg/day] intake vs. Q1 [2.6 mg/day] intake, hazard ratio [HR]: 0.52, 95% confidence interval [CI]: 0.33–0.81, p < 0.01) [48]. Using a cross-sectional study design, Shalini and associates also found a beneficial effect of carotene in DR [36]. They found that the plasma concentration of both pro-vitamin A (PVA) carotenoids (α-carotene, β-carotene, γ-carotene, α-cryptoxanthin, and β-cryptoxanthin) and non-PVA carotenoids (lutein, zeaxanthin, and lycopene) was significantly lower in the DR group compared to no DR patients and healthy controls (p < 0.001) [36]. Similarly, Zhang and associates also showed that higher dietary intake of retinol (100 μg/day) in type 2 diabetes patients was associated with a lower risk of DR (odds ratio [OR]: 0.88, 95%CI: 0.79–0.98, p = 0.025) [38]. However, the remaining three cross-sectional studies did not find significant associations between carotenoids and DR [35,44,46].

Vitamin C

The relationship between vitamin C and DR has been controversial. A longitudinal cohort study by Tanaka and co-workers showed a protective effect of increased vitamin C intake on incident DR (Q4 [183 mg/day] vs. Q1 [67 mg/day], HR: 0.61, 95%CI: 0.39–0.96, p = 0.03) [48]. The work of Tanaka et al. was the only prospective study carried out on this topic. On the contrary, a cross-sectional study by Mayer-Davis and colleagues found an increased risk for more severe DR when vitamin C intake increased from the first quintile of intake to a higher level of intake. This result, however, is significant only for the ninth decile (OR = 2.21, p = 0.011) [35]. Prospective cohort studies measure events in chronological order and can be used to distinguish between cause and effect, whereas cross-sectional studies measure parameters at a single timepoint and do not permit distinction between cause and effect. Few other studies, however, suggest no association between vitamin C intake and DR before and/or after adjustment [17,46,50].

Vitamin E

The association between Vitamin E and DR remains uncertain. She and colleagues observed Vitamin E protective effects on DR (OR: 0.97, 95%CI: 0.95–1.00, p = 0.036) in their cross-sectional study after adjusting confounding factors [17]. Similarly, Granado-Casas showed a protective effect of Vitamin E on DR (OR: 0.85, 95%CI: 0.77–0.95, p = 0.006) [40]. Contrastingly, in a cross-sectional investigation by Mayer-Davis and colleagues, an increased intake of Vitamin E was associated with increased severity of DR among those not taking insulin (10th decile vs. 1st quintile, OR: 3.79, p< 0.02) [35]. The remaining one prospective and two cross-sectional studies did not report any significant association between Vitamin E and DR [46,48,50].

Selenium

A cross-sectional study conducted on the Chinese urban population by She and associates found selenium to have a protective effect against DR (OR: 0.98, 95%CI: 0.96–1.00, p = 0.017) [17].

Riboflavin

One cross-sectional study by She and associates found no significant difference between dietary intake of riboflavin in the DR group compared to the DR group (p = 0.129) [17].

3.4.2. Vitamin D

Neither a prospective nor a case–control study found any significant association between dietary vitamin D intake and DR [43,45].

3.4.3. Choline

A cross-sectional study by Liu and associates found that a higher dietary choline intake is associated with increased odds of DR in women compared with the lowest intake group (OR: 2.14, 95%CI: 1.38–3.31; p = 0.001) when using multivariable logistic regression models. However, this association was not statistically significant in men [19].

3.4.4. Calcium

A case–control study by Alcubierre on the Spanish population found no significant association between dietary calcium intake and DR [45]. Still, their study had a small sample size (n = 283), and no adjustment of confounders was performed [45]. However, Chen and associates found a protective effect of increased dietary intake of calcium from the risk of DR (OR: 0.70, 95%CI: 0.54–0.90, p = 0.005) in their cross-sectional study on the Chinese cohort and adjusted for multiple confounders such as serum glucose, hemoglobin, and smoking status [34].

3.4.5. Potassium

Chen and associates showed that increased dietary potassium intake was associated with reduced occurrence of DR (OR: 0.76, 95%CI: 0.59–0.97, p = 0.029) in their cross-sectional study [34], whereas Tanaka and colleagues did not find any significant association between potassium intake and the risk of DR in their prospective study [48].

3.4.6. Sodium

The findings of a prospective study by Horikawa and associates indicated that, among patients who consumed less than an average of 268.7g of vegetables, high sodium intake was associated with a higher incidence of DR in elderly patients with type 2 diabetes (The results of third [4.4g/d], and fourth [5.9g/d] quartiles compared with the first quartile [2.5g/d], HRs were 2.61 [1.00–6.83], and 3.70 [1.37–10.02], respectively, p = 0.010) [37]. Another prospective study by Roy and colleagues reported increased sodium intake as a risk factor for DME progression (Q4 vs. Q1, OR: 1.43, 95%CI: 1.10–1.86, p = 0.008), but there was no significant association with DR. [49] The evidence provided by the remaining studies showed no association of sodium intake with DR [47,53,54].

3.4.7. Vitamin B6

Horikawa and associates, using a prospective study design, reported that high vitamin B6 intake was associated with a lower incidence of DR in the Japanese population with type 2 diabetes (The Q4 [2mg/day] compared with the Q1 [0.9mg/day], HR: 0.50, 95%CI: 0.30–0.85, p = 0.010) [18].

3.5. Relationship between Intake of Macronutrients to Diabetic Retinopathy

3.5.1. Fats/Fatty acids

Table 3 shows the association between monounsaturated fatty acids (MUFA; n = 9) and polyunsaturated fatty acids (PUFA; n = 8) with DR.

Monounsaturated Fatty Acids (MUFA)

A total of six studies evaluated the association between MUFA and DR. Out of these six studies, two were prospective studies, three were cross-sectional studies, and one was a case–control study (Table 3). Alcubierre and associates, who conducted a case–control study, reported that increased MUFA intake decreased DR prevalence (high MUFA intake [≥46.3g] vs. low MUFA intake [≤36.0], OR: 0.42, 95%CI: 0.18–0.97, p = 0.034) [42]. The cross-sectional study performed by Granado-Casas and associates also showed that intake of MUFA was associated with a lower frequency of DR (OR: 0.95, 95%CI: 0.92–0.99], p = 0.012) [40]. In contrast, Cundiff and associates showed an opposite relationship between MUFA intake and DR progression in their prospective study, but confounders such as HbA1c, duration of diabetes, or diabetes treatment were not adjusted [53]. The remaining studies found no significant relationships between MUFA intake and DR [46,49,52].
Oleic acid is a specific type of MUFA, and its influence on DR was evaluated by a total of three studies (one cross-sectional, one case–control, and one prospective study). A case–control study by Alcubierre and co-workers showed a protective effect of oleic acid from DR (highest intake [≥43.6] vs. lowest intake [≤32.2] OR: 0.37, 95%CI: 0.16–0.85, p = 0.017) [42]. A cross-sectional study by Granado-Casas and co-workers also reported a similar finding [40]. However, Roy and colleagues did not find any significant relationship between oleic acid and DR in their prospective study [49].

Polyunsaturated Fatty Acids (PUFA)

Sala-Vila and associates found that middle and older age type 2 diabetic patients strictly adhering to dietary long-chain omega-3 PUFA (LCω3PUFA) recommendation of at least 500mg/day was associated with a decreased risk of sight-threatening DR compared to those not fulfilling this recommendation (HR: 0.52, 95%CI: 0.31–0.88, p = 0.001) [12]. A cross-sectional study performed by Sasaki and colleagues found that among well-controlled diabetic patients, increased daily consumption of PUFAs was associated with a reduced likelihood of DR (OR: 0.18, 95%CI: 0.06–0.59), whereas an increased saturated fatty acid (SFA) intake was associated with an increased likelihood of DR (OR: 2.37, 95%CI: 1.15–4.88) [46]. In contrast, Cundiff and colleagues showed an increase in DR progression with a higher intake of PUFA, but adjustment for confounders were not performed [53]. The remaining three studies did not show significant relationships between PUFA intake and DR [42,49,52] (Table 3).
There are two interventional studies with contrasting results. One survey by Houtsmuller and associates found that subjects who consumed a diet of unsaturated fat, rich in linoleic acid, had a significant reduction in DR progression compared to those on a saturated fat diet (p < 0.01) [55]. However, Howard-Williams and colleagues assessed that participants compliant with a modified fat diet (high PUFA-to-saturated fat ratio) tended to have a lower incidence of DR than those on a low-carbohydrate diet (low PUFA-to-saturated fat ratio) [56]. Still, this difference was not statistically significant [56].

3.5.2. Carbohydrates

A cross-sectional study by Granado-Casas, using adjusted multivariate analysis, showed that intake of complex carbohydrates was positively related to the presence of DR (OR: 1.02; 95%CI: 1.00–1.04, p = 0.031) [40]. On the other hand, two studies (one cross-sectional, one prospective) showed an inverse association between carbohydrate intake and DR progression, but neither study adjusted for confounders [52,53]. The other four studies using a multivariable-adjusted model found no significant association between carbohydrate intake and DR [41,42,46,49] (Table 3).

3.5.3. Proteins

A prospective study by Park and colleagues found that the intake of glutamic acid and aspartic acid did not affect DR incidence [51]. Still, lower intake of aspartic acid showed an increased proliferative DR incidence, and the result remained consistent after adjustment (intake of aspartic acid in the highest tertile vs. lowest tertile for PDR, HR: 0.39, 95%CI: 0.16–0.96, p = 0.013) [51]. Another prospective study by Cundiff and colleagues showed that increased intake of proteins lowered progression of DR risk. Still, in their cross-sectional study, Roy and associates showed a risk relationship between protein intake and DR prevalence [52,53]. However, relevant confounders were not adjusted by these two studies. The remaining three studies, which adjusted for confounders, showed that dietary protein intake was not significantly associated with DR [42,46,49] (Table 3).

3.6. Relationship between Food Intake to Diabetic Retinopathy

3.6.1. Fruits, Vegetables and Dietary Fiber

Increased fruit, vegetable and dietary fiber consumption was associated with reduced incident DR in a prospective study conducted by Tanaka and associates (fruits intake Q4 [225.4 g/d] vs. Q1 [21.5 g/d], HR: 0.48, 95%CI: 0.32–0.71, p < 0.01; fruits and vegetables intake Q4 [670.7 g/d] vs. Q1 [232.6 g/d], HR: 0.59, 95%CI: 0.37–0.92, p = 0.01; dietary fiber intake Q4 [19.7 g/d] vs. Q1 [9.6 /d], HR: 0.63, 95%CI:0.38–1.03, p = 0.07) [48]. For dietary fiber, one prospective and two cross-sectional studies reported a protective effect on DR [52,53,57]. However, three studies (two prospective and one case–control study) reported no significant associations [21,42,49] (Table 4).

3.6.2. Rice

A prospective study by Kadri and associates found that rice consumption was significantly associated with DR occurrence (OR: 3.19, 95%CI: 1.17–8.69, p = 0.018) [20] (Table 4).

3.6.3. Cheese and Wholemeal Bread

Consumption of cheese and wholemeal bread showed a reduction in the risk of DR progression among the working-aged Australian diabetic population (cheese intake highest quartiles vs. lowest HR: 0.58, 95%CI: 0.41–0.83, p = 0.007 and wholemeal bread HR: 0.64, 95%CI: 0.46–0.89, p = 0.04) in a prospective study conducted by Yan and colleagues [21] (Table 4).

3.6.4. Fish

A prospective study by Kadri and colleagues showed that frequent fish consumption by diabetic patients reduced the risk of developing DR (OR: 0.42, 95%CI: 0.18–0.94, p < 0.05) [20]. Similarly, Chua and colleagues, using a cross-sectional design, showed that frequent fish consumption (>2 times/week) reduced the risk of DR progression (OR: 0.91, 95%CI: 0.84–0.99 per 1-unit increase in fish intake; p = 0.038) [39]. However, one cross-sectional study observed no association between fish and DR [21] (Table 4).

Fish oil

A prospective study by Sala-Vila and associates reported that consumption of two or more weekly servings of oily fish reduced the incidence of DR risk compared to those who did not consume this (HR: 0.41, 95%CI: 0.23–0.72, p < 0.002) [12]. In contrast, the association between fish oil intake and DR was found not to be significant by one prospective study [58] (Table 4).

3.6.5. Other Types of Food

No association was seen between consumption of processed meat, breakfast cereal, and seafood and DR progression in a prospective study by Yan and colleagues [21] (Table 4).

3.7. Relationship between Beverage Intake to Diabetic Retinopathy

3.7.1. Coffee

A cross-sectional study by Lee and associates showed that the consumption of ≥2 cups of coffee per day reduced the prevalence of DR (OR: 0.53, 95%CI: 0.28–0.99, p for trend = 0.025) and vision-threatening DR (OR: 0.30, 95%CI: 0.10–0.91, p for trend = 0.005) in the Korean diabetics less than 65 years of age [26]. However, in their cross-sectional study, Kumari and associates found no significant association between coffee and DR [59] (Table 5).

3.7.2. Tea

Xu and associates found that long-term tea consumption (≥20 years) in elderly diabetic Chinese residents was a protective factor for DR compared to non-tea consumers (OR: 0:29, 95%CI: 0.09–0.97, p = 0.04) in their cross-sectional study [24]. Similarly, a case–control study on the Chinese diabetic population by Ma and associates reported a protective relationship between green tea intake and DR prevalence (intake vs. no intake, OR: 0.48, 95%CI: 0.24–0.97, p = 0.04) [60] (Table 5).

3.7.3. Milk

No association was observed between milk and DR progression in a prospective study by Yan and colleagues [21] (Table 5).

3.7.4. Diet Soda

Mirghani and colleagues, using a cross-sectional study design, found that diet soda (sugar-free carbonated beverage) consumption was associated with a higher risk of DR (p = 0.043) [22]. Another cross-sectional study by Fenwick and associates also found a positive association of diet drink (>4 cans [1.5 L]/week) consumption with proliferative DR (OR: 2.62, 95%CI: 1.14–6.06, p = 0.024) [23]. Still, no association was found between regular soft drinks and DR [23] (Table 5).

3.7.5. Alcohol

A prospective study on Indians living in Singapore by Gupta and associates found that alcohol consumption was associated with a reduction in incident DR compared to non-drinkers (OR: 0.36, 95%CI: 0.13–0.98, p = 0.045). Among alcohol consumers, occasional drinkers (≤2 days/week) had reduced occurrence of incident DR (OR: 0.17, 95%CI: 0.04–0.69, p = 0.013) compared with non-drinkers [61]. The other studies, which also reported protective effect of light-to-moderate alcohol consumption on the prevalence of DR, were cross-sectional studies [62,63,64,65] (Table 5).
On the other hand, a cross-sectional study by Thapa and associates found alcohol consumption to be a significant risk factor for the development of any DR (OR: 4.3, 95%CI: 1.6–11.3, p = 0.004) and vision-threatening DR (OR:8.6, 95%CI: 1.7–47.2, p = 0.010) [66]. Similarly, a risk association was found between heavy alcohol intake and DR (heavy [>10 pints of beer/week] vs. none–moderate intake [<10 pints/week, RR: 3.5, 95%CI: 1.2–8.4, p = 0.02) in a prospective study by Young and associates [67]. A cross-sectional study also showed a risk association between alcohol and diabetic macular edema prevalence (p = 0.010) [68]. Three prospective studies, a case–control study, and a cross-sectional study did not find any association between alcohol consumption and DR [53,69,70,71,72] (Table 5).

3.8. Relationship between Broader Dietary Patterns to Diabetic Retinopathy

3.8.1. Mediterranean Dietary Pattern

Ghaemi and associates reported a significant protective effect of the Mediterranean diet against incident DR in type 1 DM (OR: 0.32, 95%CI: 0.24–0.44, p < 0.001) and type 2 DM (OR: 0.68, 95%CI: 0.61–0.71, p < 0.001) in their prospective study [25]. An interventional study showed the benefit of consumption of the Mediterranean diet on reducing the incident DR (any Mediterranean diet vs. control diet, HR: 0.60, 95%CI: 0.37–0.96) in type 2 diabetics, when using a multivariable cox regression model [73] (Table 5).

3.8.2. Total Caloric Intake

Two prospective studies by Cundiff (r = 0.07, p < 0.007) and Roy (OR:1.41, 95%CI: 1.15–1.92, p = 0.002) reported a risk associated between a high total caloric intake and DR progression [49,53] whereas Alcubierre and associates found no significant association between high caloric intake and DR in their case–control study [42] (Table 5).

4. Discussion

From our systematic review on dietary intake and DR, we found that intake of fruits, vegetables and dietary fibers, fish, Mediterranean diet, oleic acid, and tea beverages had a protective effect on DR. We also found that selenium antioxidant, vitamin B6, cheese, and wholemeal bread may have a protective effect on DR. Still, this outcome was based on only one study in each of dietary component. The consumption of diet soda, increased caloric intake, rice, and choline was found to be associated with a greater risk of DR. In contrast, no significant association was found between vitamin C, riboflavin, and vitamin D and milk with DR. Other dietary components such as carotenoids, Vitamin E, potassium, unsaturated fatty acids, carbohydrates, coffee, and alcohol showed no clear relationship with DR, signifying that more studies are needed. The assessment of the influence of dietary intake on DME is limited to only one prospective study. This study found that a high intake of sodium was associated with DME progression. The findings from our systematic review may complement the current dietary recommendations for managing DR.

4.1. Protective Associations between Dietary Intake and Diabetic Retinopathy

In our review, high levels of consumption of fruits, vegetables, and dietary fibers has revealed strong protective effects against the development of DR [48,52,53,57]. Fruits and vegetables are rich sources of fiber and antioxidant compounds [74]. Dietary fiber delays glucose absorption from the intestines, thus reducing postprandial plasma glucose levels [75]. It also reduces inflammation and oxidative stress, which are known to be involved in the initiation and progression of diabetes [74]. Thus, dietary fiber would reduce the risk of hyperglycemia and oxidative stress-induced DR [76]. Fish oil is a rich source of long-chain omega-3 polyunsaturated fatty acid (LCω3PUFAs), which reduces the risk of diabetes [77] and is found to have a protective effect on DR in our review [12,20,39]. The retina is rich in LCω3PUFAs, particularly docosahexaenoic acid (DHA), which has anti-inflammatory and anti-angiogenic properties [78,79] and experimental studies have shown the protective role of supplemental DHA or LCω3PUFAs against DR or neovascularization of the retina [80,81].
The Mediterranean diet is a centuries-old eating pattern consisting of plant-based foods such as fruits, vegetables, legumes, nuts, and whole grains. It also includes fish and olive oil and a low intake of red meat, red wine, and saturated fatty acids [82]. Our findings show the protective effect of the Mediterranean diet on DR. The anti-inflammatory and antioxidant compounds in the Mediterranean diet indirectly improve the peripheral uptake of glucose and reduce peripheral insulin resistance, and are thus proposed to have a protective effect in preventing diabetic microvascular complications [83]. Similarly, the protective role of Oleic acid against DR seen in our review is also proposed to improve peripheral insulin sensitivity. The two observational studies in the Chinese cohort in our review have shown the protective effect of tea on DR. However, results must be interpreted with caution, as these studies did not take other dietary factors such as fruits and vegetables into account [24,60]. Tea is one of the most consumed beverages in the world, and tea extracts are reported to have antioxidants and neuroprotective properties, improving insulin sensitivity, inhibiting ocular neovascularization and vascular permeability [84,85].

4.2. Adverse Associations between Dietary Intake and Diabetic Retinopathy

Two cross-sectional studies found diet soda to be a risk factor in the progression of DR. The proposed mechanism is an alteration of gut microbiota leading to inflammation, oxidative stress, and cardiometabolic states such as obesity, insulin resistance, and diabetes [86]. Another proposed theory is that the overconsumption of other food or beverages might occur due to subjects overestimating the calories saved by substituting diet beverages for sugar-sweetened drinks [23]. However, further longitudinal studies are required due to a small sample size of 200 participants [22], as well as a lack of an account of changes in diet drink, i.e. from regular soft drink to diet soft drink for lifestyle modification upon diagnosis of diabetes, which could overestimate the relationship between diet soda and DR in the study [23].
A prospective study in our review showed that increased rice consumption, which increased the total caloric intake, contributed to the increased risk of DR occurrence. A systematic review by Wong and associates found that high caloric intake increases the risk of DR [15,49,53]. Experimental and clinical evidence suggests that high caloric intake increases oxidative stress in diabetic patients, thus possibly increasing the risk of DR [87,88,89]. Interestingly, in our review, carbohydrates, one of the main contributors to total caloric intake, have shown no significant association with DR. Still, one cross-sectional study has shown a positive association with DR [40]. Despite a lack of substantial relationship with DR, it is crucial to monitor carbohydrate consumption to control postprandial hyperglycemia in patients with diabetes [90]. Thus, encouraging low-glycemic index and low-calorie meal intake may be favorable to prevent the occurrence and progression of diabetic microvascular complications [91,92]. The risk of choline causing increased DR risk for females needs further investigation by cross-sectional [19]. The literature has reported the adverse effect of choline and its metabolite, trimethylamine-N-oxide, by aggravating vascular endothelial cell dysfunction, oxidative stress, and inflammation, which are critical mechanisms of DR development [93,94].

4.3. No Significant Association between Dietary Intake and Diabetic Retinopathy

We did not find any significant association between antioxidants such as vitamin C, E, riboflavin, carotenoid intake and DR. This similar finding was also reported by Lee and associates [95]. However, in investigational studies, antioxidant supplementations inhibit oxidative stress and the development of DR [96,97]. Similarly, experimental studies have shown a beneficial effect of PUFA against the development of DR due to its anti-inflammatory and anti-angiogenic properties [81,98]. Still, the current review shows an inconclusive association. The studies in our review showing the associations of alcohol intake with DR risk have demonstrated contradictory results. Thus, our review could not confirm the protective effect of alcohol against DR, which supports the meta-analysis by Zhu and associates [99]. A moderate amount of alcohol consumption has demonstrated a beneficial effect on DR due to the high content of polyphenol, an antioxidant compound that inhibits angiogenesis, prevents inflammation, and facilitates vasorelaxation, all of which results in increased blood flow in the retina [100]. It also lowers plasma glucose levels by improving insulin sensitivity [101]. Such protective associations have been reported in a cross-sectional study and recently in a prospective study, but further longitudinal studies are required to confirm the protective association. The effect of common beverages such as milk and coffee are limited, with only one and two studies, respectively [21,26,59]. The routine diet is significantly composed of the above-listed dietary factors; thus, there is a need for large-scale longitudinal studies to understand their influence on the incidence and progression of DR.
The existing guidelines from the American Diabetic Association’s (ADA) 2022 Diabetes Standard of Care support our findings, such as the benefits of the Mediterranean diet and the consumption of fruits, vegetables, and dietary fiber in cases of diabetes [102]. The ADA also recommends an increased intake of fish containing omega-3 fatty acids, which are also seen to be effective in DR prevention in our review. The evidence regarding the benefits of antioxidant supplements is insufficient in both the research of the ADA and our review. The ADA recommends limited sodium and carbohydrate consumption; however, we found no conclusive evidence to suggest detrimental effects of increased sodium and carbohydrate. Likewise, ADA recommends PUFAs and MUFAs intake as a replacement for saturated fat. It supports modest alcohol consumption, but our study results remain inconclusive regarding the effect of MUFA / PUFA and average alcohol intake on DR [102]. The findings from our review study are intended to complement and be considered simultaneously with the existing dietary guidelines in the overall management of diabetes.

4.4. Strengths and Limitations

The systematic review has several strengths as a method. Firstly, most studies in our review had good methodological and study qualities. Secondly, only dietary intake exposure and DRs outcome within human subjects were evaluated, excluding experimental animal and biomarker studies. This allowed us to translate results into nutritional recommendations for patients. Thirdly, studies conducted on diverse populations were included, thus providing more generalized results. However, our study also has some limitations, which may cause inconclusive outcomes between dietary intake and DR. First, FFQs were mostly used in dietary assessment and were administered only once, at the study baseline. Its major limitation is inaccurate assessment due to recall bias and subjectivity across individuals. Thus, combining methods such as the FFQ with dietary records (or 24 h dietary recall) or the FFQ with biomarker levels would provide more accurate estimates of nutritional intakes than a single assessment [103]. Second, most studies were cross-sectional, limiting the establishment of a causal association of dietary factors with DR; thus, there is a need for more longitudinal studies. Third, most studies have evaluated a single dietary component or nutrient rather than a dietary pattern that examines the effects of the overall diet. Instead of focusing on a single nutrient, broader dietary patterns, including beverages, would reflect real-world food consumption habits, which would be more predictive of disease risk and help to translate into more precise dietary guidelines [104]. Fourth, only one study evaluated the influence of dietary intake on DME; thus, there is a need for future studies in order to establish a better knowledge of the mechanisms of diet on DME, which may differ from DR. Fifth, many studies did not differentiate the effect of dietary intake on type 1 and type 2 diabetes or other types of diabetes such as gestational or autoimmune which is needed as etiology, pathophysiology, epidemiology, and disease management are not similar in a different type of diabetes. Lastly, methods assessing dietary intake exposure and DR outcomes are heterogeneous, thus affecting comparability. For example, the number of DR cases in studies examined by two-field or non-mydriatic fundus photographs may be underestimated compared to studies that used stereoscopic 7-field fundus photographs (the standard reference for DR detection as defined by the ETDRS) [105]. Therefore, further studies should be conducted on all different types of diabetes.

5. Conclusions

DR affects one-third of individuals with diabetes, and multiple studies depict the association between dietary intake and diabetic eye changes. While we do not fully understand the underlying mechanism that results in or worsens DR and/or DME in people with various dietary intakes, they are likely to influence glycemic management and cardiovascular risk factors. Nonetheless, diabetic patients at risk of developing DR may benefit from nutritional recommendations, as elucidated by the studies described.

Supplementary Materials

The following are available online at https://www.mdpi.com/article/10.3390/nu14235021/s1, Table S1: PRISMA 2020 Checklist.

Author Contributions

Conceptualization, J.C.; Methodology, Z.Y.C. and J.S.; Software, Z.Y.C.; Validation, Z.Y.C., J.C. and J.S.; Formal Analysis, Z.Y.C. and J.S.; Investigation, Z.Y.C. and J.S.; Resources, J.C.; Data Curation, J.C.; Writing—Original Draft Preparation, J.S.; Writing—Review and Editing, J.S, B.T., D.W., X.L., J.C.; Visualization, J.C. and J.S.; Supervision, J.C.; Project Administration, J.C.; Funding Acquisition, J.C. All authors have read and agreed to the published version of the manuscript.

Funding

This work was funded by grants from the National Medical Research Council (CG/C010A/2017_SERI; OFLCG/004c/2018–00; MOH-000249–00; MOH-000647–00; MOH-001001–00; MOH-001015–00; MOH-000500–00; MOH-000707–00), National Research Foundation Singapore (NRF2019-THE002–0006 and NRF-CRP24–2020-0001), A*STAR (A20H4b0141), the Singapore Eye Research Institute & Nanyang Technological University (SERI-NTU Advanced Ocular Engineering (STANCE) Program), and the SERI-Lee Foundation (LF1019–1) Singapore.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Blindness, G.B.D.; Vision Impairment, C.; Vision Loss Expert Group of the Global Burden of Disease Study. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: The Right to Sight: An analysis for the Global Burden of Disease Study. Lancet Glob. Health 2021, 9, e144–e160. [Google Scholar] [CrossRef]
  2. Yau, J.W.; Rogers, S.L.; Kawasaki, R.; Lamoureux, E.L.; Kowalski, J.W.; Bek, T.; Chen, S.J.; Dekker, J.M.; Fletcher, A.; Grauslund, J.; et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 2012, 35, 556–564. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Chua, J.; Lim, C.X.Y.; Wong, T.Y.; Sabanayagam, C. Diabetic Retinopathy in the Asia-Pacific. Asia Pac. J. Ophthalmol. 2018, 7, 3–16. [Google Scholar] [CrossRef]
  4. Ogurtsova, K.; da Rocha Fernandes, J.D.; Huang, Y.; Linnenkamp, U.; Guariguata, L.; Cho, N.H.; Cavan, D.; Shaw, J.E.; Makaroff, L.E. IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res. Clin. Pract. 2017, 128, 40–50. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. Sabanayagam, C.; Banu, R.; Chee, M.L.; Lee, R.; Wang, Y.X.; Tan, G.; Jonas, J.B.; Lamoureux, E.L.; Cheng, C.Y.; Klein, B.E.K.; et al. Incidence and progression of diabetic retinopathy: A systematic review. Lancet Diabetes Endocrinol. 2019, 7, 140–149. [Google Scholar] [CrossRef] [PubMed]
  6. Fenwick, E.K.; Pesudovs, K.; Rees, G.; Dirani, M.; Kawasaki, R.; Wong, T.Y.; Lamoureux, E.L. The impact of diabetic retinopathy: Understanding the patient’s perspective. Br. J. Ophthalmol. 2011, 95, 774–782. [Google Scholar] [CrossRef]
  7. Evert, A.B.; Dennison, M.; Gardner, C.D.; Garvey, W.T.; Lau, K.H.K.; MacLeod, J.; Mitri, J.; Pereira, R.F.; Rawlings, K.; Robinson, S.; et al. Nutrition Therapy for Adults with Diabetes or Prediabetes: A Consensus Report. Diabetes Care 2019, 42, 731–754. [Google Scholar] [CrossRef] [Green Version]
  8. Bryl, A.; Mrugacz, M.; Falkowski, M.; Zorena, K. The Effect of Diet and Lifestyle on the Course of Diabetic Retinopathy-A Review of the Literature. Nutrients 2022, 14, 1252. [Google Scholar] [CrossRef]
  9. Ley, S.H.; Hamdy, O.; Mohan, V.; Hu, F.B. Prevention and management of type 2 diabetes: Dietary components and nutritional strategies. Lancet 2014, 383, 1999–2007. [Google Scholar] [CrossRef] [Green Version]
  10. Guilbert, E.; Perry, R.; Whitmarsh, A.; Sauchelli, S. Short-term effectiveness of nutrition therapy to treat type 2 diabetes in low-income and middle-income countries: Systematic review and meta-analysis of randomised controlled trials. BMJ Open 2022, 12, e056108. [Google Scholar] [CrossRef]
  11. Lima, V.C.; Cavalieri, G.C.; Lima, M.C.; Nazario, N.O.; Lima, G.C. Risk factors for diabetic retinopathy: A case–control study. Int. J. Retin. Vitr. 2016, 2, 21. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  12. Sala-Vila, A.; Díaz-López, A.; Valls-Pedret, C.; Cofán, M.; García-Layana, A.; Lamuela-Raventós, R.M.; Castañer, O.; Zanon-Moreno, V.; Martinez-Gonzalez, M.A.; Toledo, E.; et al. Dietary Marine ω-3 Fatty Acids and Incident Sight-Threatening Retinopathy in Middle-Aged and Older Individuals with Type 2 Diabetes: Prospective Investigation from the PREDIMED Trial. JAMA Ophthalmol. 2016, 134, 1142–1149. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. Chua, J.; Chia, A.; Chong, M.F.-F.; Man, R.; Tan, G.S.; Lamoureux, E.L.; Wong, T.Y.; Schmetterer, L. The Relationship of Dietary Fish Intake and Diabetic Retinopathy in Asian Patients with Type 2 Diabetes. Investig. Ophthalmol. Vis. Sci. 2017, 58, 4284. [Google Scholar]
  14. Hamad, S.; Zafar, T.A.; Sidhu, J. Parboiled rice metabolism differs in healthy and diabetic individuals with similar improvement in glycemic response. Nutrition 2018, 47, 43–49. [Google Scholar] [CrossRef]
  15. Wong, M.Y.Z.; Man, R.E.K.; Fenwick, E.K.; Gupta, P.; Li, L.J.; van Dam, R.M.; Chong, M.F.; Lamoureux, E.L. Dietary intake and diabetic retinopathy: A systematic review. PLoS ONE 2018, 13, e0186582. [Google Scholar] [CrossRef] [Green Version]
  16. Dow, C.; Mancini, F.; Rajaobelina, K.; Boutron-Ruault, M.C.; Balkau, B.; Bonnet, F.; Fagherazzi, G. Diet and risk of diabetic retinopathy: A systematic review. Eur. J. Epidemiol. 2018, 33, 141–156. [Google Scholar] [CrossRef] [PubMed]
  17. She, C.; Shang, F.; Cui, M.; Yang, X.; Liu, N. Association between dietary antioxidants and risk for diabetic retinopathy in a Chinese population. Eye 2021, 35, 1977–1984. [Google Scholar] [CrossRef] [PubMed]
  18. Horikawa, C.; Aida, R.; Kamada, C.; Fujihara, K.; Tanaka, S.; Tanaka, S.; Araki, A.; Yoshimura, Y.; Moriya, T.; Akanuma, Y.; et al. Vitamin B6 intake and incidence of diabetic retinopathy in Japanese patients with type 2 diabetes: Analysis of data from the Japan Diabetes Complications Study (JDCS). Eur. J. Nutr. 2020, 59, 1585–1594. [Google Scholar] [CrossRef] [PubMed]
  19. Liu, W.; Ren, C.; Zhang, W.; Liu, G.; Lu, P. Association between Dietary Choline Intake and Diabetic Retinopathy: National Health and Nutrition Examination Survey 2005–2008. Curr. Eye Res. 2022, 47, 269–276. [Google Scholar] [CrossRef]
  20. Kadri, R.; Vishwanath, P.; Parameshwar, D.; Hegde, S.; Kudva, A.A. Dietary associations with diabetic retinopathy-A cohort study. Indian J. Ophthalmol. 2021, 69, 661–665. [Google Scholar] [CrossRef] [PubMed]
  21. Yan, X.; Han, X.; Wu, C.; Keel, S.; Shang, X.; Zhang, L.; He, M. Does daily dietary intake affect diabetic retinopathy progression? 10-year results from the 45 and Up Study. Br. J. Ophthalmol. 2020, 104, 1774–1780. [Google Scholar] [CrossRef] [PubMed]
  22. Mirghani, H.; Alali, N.; Albalawi, H.; ALselaimy, R. Diet Sugar-Free Carbonated Soda Beverage, Non-Caloric Flavors Consumption, and Diabetic Retinopathy: Any Linkage. Diabetes Metab. Syndr. Obes. 2021, 14, 2309–2315. [Google Scholar] [CrossRef] [PubMed]
  23. Fenwick, E.K.; Gan, A.T.; Man, R.E.; Sabanayagam, C.; Gupta, P.; Khoo, K.; Aravindhan, A.; Wong, T.Y.; Lamoureux, E.L. Diet soft drink is associated with increased odds of proliferative diabetic retinopathy. Clin. Exp. Ophthalmol. 2018, 46, 767–776. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Xu, C.; Bi, M.; Jin, X.; Zhu, M.; Wang, G.; Zhao, P.; Qin, X.; Xu, X.; Sun, X.; Ji, N.; et al. Long-Term Tea Consumption Is Associated with Reduced Risk of Diabetic Retinopathy: A Cross-Sectional Survey among Elderly Chinese from Rural Communities. J. Diabetes Res. 2020, 2020, 1860452. [Google Scholar] [CrossRef] [PubMed]
  25. Ghaemi, F.; Firouzabadi, F.D.; Moosaie, F.; Shadnoush, M.; Poopak, A.; Kermanchi, J.; Abhari, S.M.F.; Forouzanfar, R.; Mansournia, M.A.; Khosravi, A.; et al. Effects of a Mediterranean diet on the development of diabetic complications: A longitudinal study from the nationwide diabetes report of the National Program for Prevention and Control of Diabetes (NPPCD 2016–2020). Maturitas 2021, 153, 61–67. [Google Scholar] [CrossRef] [PubMed]
  26. Lee, H.J.; Park, J.I.; Kwon, S.O.; Hwang, D.D. Coffee consumption and diabetic retinopathy in adults with diabetes mellitus. Sci. Rep. 2022, 12, 3547. [Google Scholar] [CrossRef]
  27. Agrawal, R.; Gupta, P.; Tan, K.A.; Cheung, C.M.; Wong, T.Y.; Cheng, C.Y. Choroidal vascularity index as a measure of vascular status of the choroid: Measurements in healthy eyes from a population-based study. Sci. Rep. 2016, 6, 21090. [Google Scholar] [CrossRef] [Green Version]
  28. Nian, S.; Lo, A.C.Y.; Mi, Y.; Ren, K.; Yang, D. Neurovascular unit in diabetic retinopathy: Pathophysiological roles and potential therapeutical targets. Eye Vis. 2021, 8, 15. [Google Scholar] [CrossRef]
  29. Page, M.J.; McKenzie, J.E.; Bossuyt, P.M.; Boutron, I.; Hoffmann, T.C.; Mulrow, C.D.; Shamseer, L.; Tetzlaff, J.M.; Akl, E.A.; Brennan, S.E.; et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ 2021, 372, n71. [Google Scholar] [CrossRef]
  30. Wu, L.; Fernandez-Loaiza, P.; Sauma, J.; Hernandez-Bogantes, E.; Masis, M. Classification of diabetic retinopathy and diabetic macular edema. World J. Diabetes 2013, 4, 290–294. [Google Scholar] [CrossRef]
  31. Deeks, J.J.; Dinnes, J.; D’Amico, R.; Sowden, A.J.; Sakarovitch, C.; Song, F.; Petticrew, M.; Altman, D.G. Evaluating non-randomised intervention studies. Health Technol. Assess. 2003, 7, 1–173. [Google Scholar] [CrossRef] [PubMed]
  32. Wells, G.A.; Shea, B.; O’Connell, D.; Peterson, J.; Welch, V.; Losos, M.; Tugwell, P. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses. Available online: https://web.archive.org/web/20210716121605id_/http://www3.med.unipmn.it/dispense_ebm/2009-2010/Corso%20Perfezionamento%20EBM_Faggiano/NOS_oxford.pdf (accessed on 6 October 2022).
  33. Higgins, J.P.T.; Altman, D.G.; Gøtzsche, P.C.; Jüni, P.; Moher, D.; Oxman, A.D.; Savović, J.; Schulz, K.F.; Weeks, L.; Sterne, J.A.C. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ 2011, 343, d5928. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  34. Chen, Y.Y.; Chen, Y.J. Association between Dietary Calcium and Potassium and Diabetic Retinopathy: A Cross-Sectional Retrospective Study. Nutrients 2022, 14, 1086. [Google Scholar] [CrossRef] [PubMed]
  35. Mayer-Davis, E.J.; Bell, R.A.; Reboussin, B.A.; Rushing, J.; Marshall, J.A.; Hamman, R.F. Antioxidant nutrient intake and diabetic retinopathy. Ophthalmology 1998, 105, 2264–2270. [Google Scholar] [CrossRef]
  36. Shalini, T.; Jose, S.S.; Prasanthi, P.S.; Balakrishna, N.; Viswanath, K.; Reddy, G.B. Carotenoid status in type 2 diabetes patients with and without retinopathy. Food Funct. 2021, 12, 4402–4410. [Google Scholar] [CrossRef]
  37. Horikawa, C.; Aida, R.; Tanaka, S.; Kamada, C.; Tanaka, S.; Yoshimura, Y.; Kodera, R.; Fujihara, K.; Kawasaki, R.; Moriya, T.; et al. Sodium Intake and Incidence of Diabetes Complications in Elderly Patients with Type 2 Diabetes-Analysis of Data from the Japanese Elderly Diabetes Intervention Study (J-EDIT). Nutrients 2021, 13, 689. [Google Scholar] [CrossRef]
  38. Zhang, C.; Li, K.; Zhang, J.; Kuang, X.; Liu, C.; Deng, Q.; Li, D. Relationship between retinol and risk of diabetic retinopathy: A case-control study. Asia Pac. J. Clin. Nutr. 2019, 28, 607–613. [Google Scholar] [CrossRef]
  39. Chua, J.; Chia, A.R.; Chee, M.L.; Man, R.E.K.; Tan, G.S.W.; Lamoureux, E.L.; Wong, T.Y.; Chong, M.F.; Schmetterer, L. The relationship of dietary fish intake to diabetic retinopathy and retinal vascular caliber in patients with type 2 diabetes. Sci. Rep. 2018, 8, 730. [Google Scholar] [CrossRef] [Green Version]
  40. Granado-Casas, M.; Ramírez-Morros, A.; Martín, M.; Real, J.; Alonso, N.; Valldeperas, X.; Traveset, A.; Rubinat, E.; Alcubierre, N.; Hernández, M.; et al. Type 1 Diabetic Subjects with Diabetic Retinopathy Show an Unfavorable Pattern of Fat Intake. Nutrients 2018, 10, 1184. [Google Scholar] [CrossRef] [Green Version]
  41. Horikawa, C.; Yoshimura, Y.; Kamada, C.; Tanaka, S.; Tanaka, S.; Matsunaga, S.; Hanyu, O.; Araki, A.; Ito, H.; Tanaka, A.; et al. Is the Proportion of Carbohydrate Intake Associated with the Incidence of Diabetes Complications?—An Analysis of the Japan Diabetes Complications Study. Nutrients 2017, 9, 113. [Google Scholar] [CrossRef] [Green Version]
  42. Alcubierre, N.; Navarrete-Muñoz, E.M.; Rubinat, E.; Falguera, M.; Valls, J.; Traveset, A.; Vilanova, M.B.; Marsal, J.R.; Hernandez, M.; Granado-Casas, M.; et al. Association of low oleic acid intake with diabetic retinopathy in type 2 diabetic patients: A case-control study. Nutr. Metab. 2016, 13, 40. [Google Scholar] [CrossRef] [PubMed]
  43. Millen, A.E.; Sahli, M.W.; Nie, J.; LaMonte, M.J.; Lutsey, P.L.; Klein, B.E.; Mares, J.A.; Meyers, K.J.; Andrews, C.A.; Klein, R. Adequate vitamin D status is associated with the reduced odds of prevalent diabetic retinopathy in African Americans and Caucasians. Cardiovasc. Diabetol. 2016, 15, 128. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  44. Sahli, M.W.; Mares, J.A.; Meyers, K.J.; Klein, R.; Brady, W.E.; Klein, B.E.; Ochs-Balcom, H.M.; Donahue, R.P.; Millen, A.E. Dietary Intake of Lutein and Diabetic Retinopathy in the Atherosclerosis Risk in Communities Study (ARIC). Ophthalmic Epidemiol. 2016, 23, 99–108. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  45. Alcubierre, N.; Valls, J.; Rubinat, E.; Cao, G.; Esquerda, A.; Traveset, A.; Granado-Casas, M.; Jurjo, C.; Mauricio, D. Vitamin D Deficiency Is Associated with the Presence and Severity of Diabetic Retinopathy in Type 2 Diabetes Mellitus. J. Diabetes Res. 2015, 2015, 374178. [Google Scholar] [CrossRef] [PubMed]
  46. Sasaki, M.; Kawasaki, R.; Rogers, S.; Man, R.E.; Itakura, K.; Xie, J.; Flood, V.; Tsubota, K.; Lamoureux, E.; Wang, J.J. The Associations of Dietary Intake of Polyunsaturated Fatty Acids with Diabetic Retinopathy in Well-Controlled Diabetes. Investig. Ophthalmol. Vis. Sci. 2015, 56, 7473–7479. [Google Scholar] [CrossRef]
  47. Horikawa, C.; Yoshimura, Y.; Kamada, C.; Tanaka, S.; Tanaka, S.; Hanyu, O.; Araki, A.; Ito, H.; Tanaka, A.; Ohashi, Y.; et al. Dietary sodium intake and incidence of diabetes complications in Japanese patients with type 2 diabetes: Analysis of the Japan Diabetes Complications Study (JDCS). J. Clin. Endocrinol. Metab. 2014, 99, 3635–3643. [Google Scholar] [CrossRef] [Green Version]
  48. Tanaka, S.; Yoshimura, Y.; Kawasaki, R.; Kamada, C.; Tanaka, S.; Horikawa, C.; Ohashi, Y.; Araki, A.; Ito, H.; Akanuma, Y.; et al. Fruit intake and incident diabetic retinopathy with type 2 diabetes. Epidemiology 2013, 24, 204–211. [Google Scholar] [CrossRef]
  49. Roy, M.S.; Janal, M.N. High caloric and sodium intakes as risk factors for progression of retinopathy in type 1 diabetes mellitus. Arch. Ophthalmol. 2010, 128, 33–39. [Google Scholar] [CrossRef] [Green Version]
  50. Millen, A.E.; Klein, R.; Folsom, A.R.; Stevens, J.; Palta, M.; Mares, J.A. Relation between intake of vitamins C and E and risk of diabetic retinopathy in the Atherosclerosis Risk in Communities Study. Am. J. Clin. Nutr. 2004, 79, 865–873. [Google Scholar] [CrossRef] [Green Version]
  51. Park, S.Y.; Kim, J.; Son, J.I.; Rhee, S.Y.; Kim, D.Y.; Chon, S.; Lim, H.; Woo, J.T. Dietary glutamic acid and aspartic acid as biomarkers for predicting diabetic retinopathy. Sci. Rep. 2021, 11, 7244. [Google Scholar] [CrossRef]
  52. Roy, M.S.; Stables, G.; Collier, B.; Roy, A.; Bou, E. Nutritional factors in diabetics with and without retinopathy. Am. J. Clin. Nutr. 1989, 50, 728–730. [Google Scholar] [CrossRef] [PubMed]
  53. Cundiff, D.K.; Nigg, C.R. Diet and diabetic retinopathy: Insights from the Diabetes Control and Complications Trial (DCCT). MedGenMed. 2005, 7, 3. [Google Scholar]
  54. Engelen, L.; Soedamah-Muthu, S.S.; Geleijnse, J.M.; Toeller, M.; Chaturvedi, N.; Fuller, J.H.; Schalkwijk, C.G.; Stehouwer, C.D. Higher dietary salt intake is associated with microalbuminuria, but not with retinopathy in individuals with type 1 diabetes: The EURODIAB Prospective Complications Study. Diabetologia 2014, 57, 2315–2323. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  55. Houtsmuller, A.J.; Zahn, K.J.; Henkes, H.E. Unsaturated fats and progression of diabetic retinopathy. Doc. Ophthalmol. 1980, 48, 363–371. [Google Scholar] [CrossRef]
  56. Howard-Williams, J.; Patel, P.; Jelfs, R.; Carter, R.D.; Awdry, P.; Bron, A.; Mann, J.I.; Hockaday, T.D. Polyunsaturated fatty acids and diabetic retinopathy. Br. J. Ophthalmol. 1985, 69, 15–18. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  57. Ganesan, S.; Raman, R.; Kulothungan, V.; Sharma, T. Influence of dietary-fibre intake on diabetes and diabetic retinopathy: Sankara Nethralaya-Diabetic Retinopathy Epidemiology and Molecular Genetic Study (report 26). Clin. Exp. Ophthalmol. 2012, 40, 288–294. [Google Scholar] [CrossRef]
  58. Alsbirk, K.E.; Seland, J.H.; Assmus, J. Diabetic retinopathy and visual impairment in a Norwegian diabetic coast population with a high dietary intake of fish oils. Obs. Study. Acta Ophthalmol. 2022, 100, e532–e538. [Google Scholar] [CrossRef] [PubMed]
  59. Kumari, N.; Li, X.; Wong, W.-L.; Tai, S.E.; Lee, J.; van Dam, R.M.; Wong, T.-Y. Is Coffee Consumption associated with Age-related Macular Degeneration and Diabetic Retinopathy? All Results J. Biol. 2014, 5, 7–13. [Google Scholar]
  60. Ma, Q.; Chen, D.; Sun, H.P.; Yan, N.; Xu, Y.; Pan, C.W. Regular Chinese Green Tea Consumption is Protective for Diabetic Retinopathy: A Clinic-Based Case-Control Study. J. Diabetes Res. 2015, 2015, 231570. [Google Scholar] [CrossRef] [Green Version]
  61. Gupta, P.; Fenwick, E.K.; Sabanayagam, C.; Gan, A.T.L.; Tham, Y.C.; Thakur, S.; Man, R.E.K.; Mitchell, P.; Wong, T.Y.; Cheng, C.Y.; et al. Association of alcohol intake with incidence and progression of diabetic retinopathy. Br. J. Ophthalmol. 2021, 105, 538–542. [Google Scholar] [CrossRef]
  62. Fenwick, E.K.; Xie, J.; Man, R.E.; Lim, L.L.; Flood, V.M.; Finger, R.P.; Wong, T.Y.; Lamoureux, E.L. Moderate consumption of white and fortified wine is associated with reduced odds of diabetic retinopathy. J. Diabetes Complicat. 2015, 29, 1009–1014. [Google Scholar] [CrossRef] [PubMed]
  63. Beulens, J.W.; Kruidhof, J.S.; Grobbee, D.E.; Chaturvedi, N.; Fuller, J.H.; Soedamah-Muthu, S.S. Alcohol consumption and risk of microvascular complications in type 1 diabetes patients: The EURODIAB Prospective Complications Study. Diabetologia 2008, 51, 1631–1638. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  64. Harjutsalo, V.; Feodoroff, M.; Forsblom, C.; Groop, P.H.; FinnDiane Study Group. Patients with Type 1 diabetes consuming alcoholic spirits have an increased risk of microvascular complications. Diabet. Med. 2014, 31, 156–164. [Google Scholar] [CrossRef]
  65. Moss, S.E.; Klein, R.; Klein, B.E.K. Alcohol Consumption and the Prevalence of Diabetic Retinopathy. Ophthalmology 1992, 99, 926–932. [Google Scholar] [CrossRef]
  66. Thapa, R.; Twyana, S.N.; Paudyal, G.; Khanal, S.; van Nispen, R.; Tan, S.; Thapa, S.S.; van Rens, G. Prevalence and risk factors of diabetic retinopathy among an elderly population with diabetes in Nepal: The Bhaktapur Retina Study. Clin. Ophthalmol. 2018, 12, 561–568. [Google Scholar] [CrossRef] [Green Version]
  67. Young, R.J.; McCulloch, D.K.; Prescott, R.J.; Clarke, B.F. Alcohol: Another risk factor for diabetic retinopathy? Br. Med. J. Clin. Res. Ed. 1984, 288, 1035–1037. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  68. Acan, D.; Calan, M.; Er, D.; Arkan, T.; Kocak, N.; Bayraktar, F.; Kaynak, S. The prevalence and systemic risk factors of diabetic macular edema: A cross-sectional study from Turkey. BMC Ophthalmol. 2018, 18, 91. [Google Scholar] [CrossRef] [Green Version]
  69. Kawasaki, R.; Kitano, S.; Sato, Y.; Yamashita, H.; Nishimura, R.; Tajima, N.; Japan Diabetes, C.; For the Japan Diabetes Complication and its Prevention prospective (JDCP) study Diabetic Retinopathy working group. Factors associated with non-proliferative diabetic retinopathy in patients with type 1 and type 2 diabetes: The Japan Diabetes Complication and its Prevention prospective study (JDCP study 4). Diabetol. Int. 2019, 10, 3–11. [Google Scholar] [CrossRef]
  70. Giuffre, G.; Lodato, G.; Dardanoni, G. Prevalence and risk factors of diabetic retinopathy in adult and elderly subjects: The Casteldaccia Eye Study. Graefes Arch. Clin. Exp. Ophthalmol. 2004, 242, 535–540. [Google Scholar] [CrossRef]
  71. Lee, C.C.; Stolk, R.P.; Adler, A.I.; Patel, A.; Chalmers, J.; Neal, B.; Poulter, N.; Harrap, S.; Woodward, M.; Marre, M.; et al. Association between alcohol consumption and diabetic retinopathy and visual acuity-the AdRem Study. Diabet. Med. 2010, 27, 1130–1137. [Google Scholar] [CrossRef] [Green Version]
  72. Moss, S.E.; Klein, R.; Klein, B.E.K. The Association of Alcohol Consumption with the Incidence and Progression of Diabetic Retinopathy. Ophthalmology 1994, 101, 1962–1968. [Google Scholar] [CrossRef] [PubMed]
  73. Diaz-Lopez, A.; Babio, N.; Martinez-Gonzalez, M.A.; Corella, D.; Amor, A.J.; Fito, M.; Estruch, R.; Aros, F.; Gomez-Gracia, E.; Fiol, M.; et al. Mediterranean Diet, Retinopathy, Nephropathy, and Microvascular Diabetes Complications: A Post Hoc Analysis of a Randomized Trial. Diabetes Care 2015, 38, 2134–2141. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  74. Wang, P.Y.; Fang, J.C.; Gao, Z.H.; Zhang, C.; Xie, S.Y. Higher intake of fruits, vegetables or their fiber reduces the risk of type 2 diabetes: A meta-analysis. J. Diabetes Investig. 2016, 7, 56–69. [Google Scholar] [CrossRef]
  75. McRae, M.P. Dietary Fiber Intake and Type 2 Diabetes Mellitus: An Umbrella Review of Meta-analyses. J. Chiropr. Med. 2018, 17, 44–53. [Google Scholar] [CrossRef] [PubMed]
  76. Kang, Q.; Yang, C. Oxidative stress and diabetic retinopathy: Molecular mechanisms, pathogenetic role and therapeutic implications. Redox Biol. 2020, 37, 101799. [Google Scholar] [CrossRef] [PubMed]
  77. Gao, H.; Geng, T.; Huang, T.; Zhao, Q. Fish oil supplementation and insulin sensitivity: A systematic review and meta-analysis. Lipids Health Dis. 2017, 16, 131. [Google Scholar] [CrossRef] [Green Version]
  78. SanGiovanni, J.P.; Chew, E.Y. The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina. Prog. Retin. Eye Res. 2005, 24, 87–138. [Google Scholar] [CrossRef]
  79. Das, U.N. Lipoxins, resolvins, and protectins in the prevention and treatment of diabetic macular edema and retinopathy. Nutrition 2013, 29, 1–7. [Google Scholar] [CrossRef]
  80. Connor, K.M.; SanGiovanni, J.P.; Lofqvist, C.; Aderman, C.M.; Chen, J.; Higuchi, A.; Hong, S.; Pravda, E.A.; Majchrzak, S.; Carper, D.; et al. Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis. Nat. Med. 2007, 13, 868–873. [Google Scholar] [CrossRef] [Green Version]
  81. Tikhonenko, M.; Lydic, T.A.; Opreanu, M.; Li Calzi, S.; Bozack, S.; McSorley, K.M.; Sochacki, A.L.; Faber, M.S.; Hazra, S.; Duclos, S.; et al. N-3 polyunsaturated Fatty acids prevent diabetic retinopathy by inhibition of retinal vascular damage and enhanced endothelial progenitor cell reparative function. PLoS ONE 2013, 8, e55177. [Google Scholar] [CrossRef] [Green Version]
  82. Benson, G.; Pereira, R.F.; Boucher, J.L. Rationale for the Use of a Mediterranean Diet in Diabetes Management. Diabetes Spectr. 2011, 24, 36–40. [Google Scholar] [CrossRef] [Green Version]
  83. Martín-Peláez, S.; Fito, M.; Castaner, O. Mediterranean Diet Effects on Type 2 Diabetes Prevention, Disease Progression, and Related Mechanisms. A Review. Nutrients 2020, 12, 2236. [Google Scholar] [CrossRef] [PubMed]
  84. Silva, K.C.; Rosales, M.A.B.; Hamassaki, D.E.; Saito, K.C.; Faria, A.M.; Ribeiro, P.A.O.; Lopes de Faria, J.B.; Lopes de Faria, J.M. Green Tea Is Neuroprotective in Diabetic Retinopathy. Investig. Ophthalmol. Vis. Sci. 2013, 54, 1325–1336. [Google Scholar] [CrossRef] [PubMed]
  85. Lee, H.S.; Jun, J.H.; Jung, E.H.; Koo, B.A.; Kim, Y.S. Epigalloccatechin-3-gallate inhibits ocular neovascularization and vascular permeability in human retinal pigment epithelial and human retinal microvascular endothelial cells via suppression of MMP-9 and VEGF activation. Molecules 2014, 19, 12150–12172. [Google Scholar] [CrossRef] [Green Version]
  86. Gardener, H.; Moon, Y.P.; Rundek, T.; Elkind, M.S.V.; Sacco, R.L. Diet Soda and Sugar-Sweetened Soda Consumption in Relation to Incident Diabetes in the Northern Manhattan Study. Curr. Dev. Nutr. 2018, 2, nzy008. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  87. Archer, D.B. Bowman Lecture 1998. Diabetic retinopathy: Some cellular, molecular and therapeutic considerations. Eye 1999, 13 Pt 4, 497–523. [Google Scholar] [CrossRef] [Green Version]
  88. Skrha, J.; Kunesová, M.; Hilgertová, J.; Weiserová, H.; Krízová, J.; Kotrlíková, E. Short-term very low calorie diet reduces oxidative stress in obese type 2 diabetic patients. Physiol. Res. 2005, 54, 33–39. [Google Scholar] [CrossRef]
  89. Zubrzycki, A.; Cierpka-Kmiec, K.; Kmiec, Z.; Wronska, A. The role of low-calorie diets and intermittent fasting in the treatment of obesity and type-2 diabetes. J. Physiol. Pharmacol. 2018, 69, 663–683. [Google Scholar] [CrossRef]
  90. Lennerz, B.S.; Koutnik, A.P.; Azova, S.; Wolfsdorf, J.I.; Ludwig, D.S. Carbohydrate restriction for diabetes: Rediscovering centuries-old wisdom. J. Clin. Investig. 2021, 131, e142246. [Google Scholar] [CrossRef]
  91. Chiu, C.J.; Taylor, A. Dietary hyperglycemia, glycemic index and metabolic retinal diseases. Prog. Retin. Eye Res. 2011, 30, 18–53. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  92. Thomas, D.; Elliott, E.J. Low glycaemic index, or low glycaemic load, diets for diabetes mellitus. Cochrane Database Syst. Rev. 2009, 2009, Cd006296. [Google Scholar] [CrossRef] [PubMed]
  93. Seldin, M.M.; Meng, Y.; Qi, H.; Zhu, W.; Wang, Z.; Hazen, S.L.; Lusis, A.J.; Shih, D.M. Trimethylamine N-Oxide Promotes Vascular Inflammation Through Signaling of Mitogen-Activated Protein Kinase and Nuclear Factor-κB. J. Am. Heart Assoc. 2016, 5, e002767. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  94. Chen, M.L.; Zhu, X.H.; Ran, L.; Lang, H.D.; Yi, L.; Mi, M.T. Trimethylamine-N-Oxide Induces Vascular Inflammation by Activating the NLRP3 Inflammasome Through the SIRT3-SOD2-mtROS Signaling Pathway. J. Am. Heart Assoc. 2017, 6, e006347. [Google Scholar] [CrossRef]
  95. Lee, C.T.; Gayton, E.L.; Beulens, J.W.; Flanagan, D.W.; Adler, A.I. Micronutrients and diabetic retinopathy a systematic review. Ophthalmology 2010, 117, 71–78. [Google Scholar] [CrossRef]
  96. Kowluru, R.A.; Tang, J.; Kern, T.S. Abnormalities of retinal metabolism in diabetes and experimental galactosemia. VII. Effect of long-term administration of antioxidants on the development of retinopathy. Diabetes 2001, 50, 1938–1942. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  97. Kowluru, R.A.; Kanwar, M.; Chan, P.S.; Zhang, J.P. Inhibition of retinopathy and retinal metabolic abnormalities in diabetic rats with AREDS-based micronutrients. Arch. Ophthalmol. 2008, 126, 1266–1272. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  98. Shen, J.H.; Ma, Q.; Shen, S.R.; Xu, G.T.; Das, U.N. Effect of α-linolenic acid on streptozotocin-induced diabetic retinopathy indices in vivo. Arch. Med. Res. 2013, 44, 514–520. [Google Scholar] [CrossRef]
  99. Zhu, W.; Meng, Y.F.; Wu, Y.; Xu, M.; Lu, J. Association of alcohol intake with risk of diabetic retinopathy: A meta-analysis of observational studies. Sci. Rep. 2017, 7, 4. [Google Scholar] [CrossRef] [Green Version]
  100. Bola, C.; Bartlett, H.; Eperjesi, F. Resveratrol and the eye: Activity and molecular mechanisms. Graefes Arch. Clin. Exp. Ophthalmol. 2014, 252, 699–713. [Google Scholar] [CrossRef] [Green Version]
  101. Albert, M.A.; Glynn, R.J.; Ridker, P.M. Plasma concentration of C-reactive protein and the calculated Framingham Coronary Heart Disease Risk Score. Circulation 2003, 108, 161–165. [Google Scholar] [CrossRef] [Green Version]
  102. American Diabetes, A. Professional Practice Committee: Standards of Medical Care in Diabetes—2022. Diabetes Care 2021, 45, S3. [Google Scholar] [CrossRef]
  103. Shim, J.-S.; Oh, K.; Kim, H.C. Dietary assessment methods in epidemiologic studies. Epidemiol. Health 2014, 36, e2014009. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  104. Hu, F.B. Dietary pattern analysis: A new direction in nutritional epidemiology. Curr. Opin. Lipidol. 2002, 13, 3–9. [Google Scholar] [CrossRef] [PubMed]
  105. Grading diabetic retinopathy from stereoscopic color fundus photographs—An extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology 1991, 98, 786–806. [CrossRef]
Figure 1. (A) Color fundus photograph of a diabetic individual without retinopathy. (B) Color fundus photograph of a diabetic individual with signs of moderate non-proliferative diabetic retinopathy. Notably, features include microaneurysms (red arrows), dot-and-blot hemorrhages (white arrows), and hard exudates (blue arrows, HE).
Figure 1. (A) Color fundus photograph of a diabetic individual without retinopathy. (B) Color fundus photograph of a diabetic individual with signs of moderate non-proliferative diabetic retinopathy. Notably, features include microaneurysms (red arrows), dot-and-blot hemorrhages (white arrows), and hard exudates (blue arrows, HE).
Nutrients 14 05021 g001
Figure 2. PRISMA flow diagram for the systematic review detailing the database searches, the number of abstracts screened, and the full texts retrieved. * Some studies analyzed >1 dietary component.
Figure 2. PRISMA flow diagram for the systematic review detailing the database searches, the number of abstracts screened, and the full texts retrieved. * Some studies analyzed >1 dietary component.
Nutrients 14 05021 g002
Figure 3. An overview of dietary components based on the studies included in the systematic review. The number assigned to the dietary component corresponds to the results section for easy referencing.
Figure 3. An overview of dietary components based on the studies included in the systematic review. The number assigned to the dietary component corresponds to the results section for easy referencing.
Nutrients 14 05021 g003
Figure 4. Risk of bias by the domain (in bold) and specific regions in (A) 17 prospective, (B) 29 cross-sectional, and (C) 5 case–control studies using the Newcastle–Ottawa Scale. Numbers on the green bar represent the number of studies with a low risk of bias over the number of studies assessed.
Figure 4. Risk of bias by the domain (in bold) and specific regions in (A) 17 prospective, (B) 29 cross-sectional, and (C) 5 case–control studies using the Newcastle–Ottawa Scale. Numbers on the green bar represent the number of studies with a low risk of bias over the number of studies assessed.
Nutrients 14 05021 g004
Table 1. Characteristics of studies (n = 54).
Table 1. Characteristics of studies (n = 54).
Study, Year
Sample Size
Diabetes TypeAgeDietary FactorDiet EvaluationDR OutcomeDR EvaluationClassification of DRQuality
Score
3 Interventional studies
Houtsmuller et al., 1979
n = 96
Any diabetesNot statedSaturated fat diet vs. unsaturated fat dietNAIncidence and progressionFundus photographNone, NPDR, PDR, PRPHigh bias
Howard-Williams et al., 1985
n = 149
Any diabetes<66Saturated fat diet vs. unsaturated fat dietNAIncidenceOphthalmologist examinationNone, retinopathyHigh bias
Diaz-Lopez et al., 2015
n = 3614
T2DM55–80Mediterranean dietNAIncidenceOphthalmologist examinationNone, NPDR, PDRModerate bias
17 Prospective studies
Horikawa et al., 2021
T2DM: 912
T2DM65–85SodiumValidated food frequency questionnaireIncidenceOphthalmologist examinationJapanese Diabetes Complication Study Method10
Park et al., 2021
DR: 731
no DR: 1336
T2DMDR: 53.1 (9.7)
no DR: 55.6 (9.7)
Glutamic acid and aspartic acid3-day food record with computer-aided nutritional analysisIncidenceFundus photograph, OCTETDRS10
Horikawa et al., 2017
n = 936
T2DM40–70CarbohydratesValidated food frequency questionnaireIncidence and progressionOphthalmologist examinationInternational Classification System10
Horikawa et al., 2014
n = 978
T2DM40–70SodiumValidated food frequency questionnaireIncidence and progressionOphthalmologist examinationInternational Classification System10
Tanaka et al., 2013
n = 978
T2DM40–70Vitamin C, Vitamin E, carotenoids, fruits, and vegetables,Validated food frequency questionnaire + 24 h dietary recallIncidenceOphthalmologist examinationInternational Classification System10
Hainsworth et al., 2019
PDR: 379
no PDR: 1061
T1DMPDR: 26 (21–32)
no PDR: 27 (22–32)
Alcohol beverageSimple background questionnaireIncidence and progressionStandardized stereoscopic seven-field fundus photographsETDRS9
Horikawa et al., 2019
n = 978
T2DM40–70Vitamin B6Validated food frequency questionnaireIncidenceMydriatic indirect ophthalmoscopic examination and slit lamp biomicroscopic fundus examination, with supplementation of fundus photography and fluorescein angiographyInternational Clinical Diabetic Retinopathy, DME Severity Scale9
Sala-Vila et al., 2016
n = 3482
T2DM55–80Long-chain omega-3 polyunsaturated fatty acids and oily FishValidated food frequency questionnaireIncidenceClinical and hospital recordsNone, NPDR, PDR9
Lee et al., 2010
n = 1239
T2DM55–81AlcoholSelf-report in a general questionnaireProgressionFundus photographModified ETDRS9
Roy et al., 2010
n = 469
T1DMMen: 26.7 (10.7)
Women: 27.8 (10.8)
MUFA, PUFA, oleic acid, protein, dietary fiber, carbohydrates, sodium, total calories, alcoholValidated food frequency questionnaireIncidence and progressionFundus photographModified ETDRS9
Moss et al., 1993
Young: 439
Older: 478
Any diabetes21–94AlcoholSelf-report in a general questionnaireIncidence and progressionFundus photographModified ETDRS9
Gupta et al., 2020
Abstainers: 563
Consumers: 93
Not statedAbstainers: 58.88 (9.45)
Consumers: 58.41 (8.09)
AlcoholQuestionnaire on alcohol consumptionIncidence and progressionFundus photographETDRS, Airlie House Classification8
Cundiff et al., 2005
n = 1412
T1DM13–39MUFA, PUFA, carbohydrates, protein, dietary fiber, sodium, alcohol, high caloriesDietary history interviewProgressionFundus photographModified ETDRS8
Young et al., 1984
n = 296
Any diabetes20–59AlcoholSelf-report in a general questionnaireIncidenceDirect ophthalmoscopyModified ETDRS8
Ghaemi et al., 2021
T1DM with MD: 1669
T1DM without MD: 180
T2DM with MD: 15886
T2DM without MD: 4452
T1DM or T2DMT1DM with MD: 50.63 (20.11)
T1DM without MD: 51.40 (16.20)
T2DM with MD: 59.78 11.00)
Mediterranean diet14 item questionnaireIncidenceRecords from the National Program for Prevention and Control of Diabetes of Iran databaseInternational Classification of Diseases, 10th Revision: E10.3, E11.3, E12.3, E13.3, and E14.37
Kadri et al., 2021
DR: 106
no DR: 155
T2DM57.73 (11.29)Alcohol, antioxidants, milk, tea, coffee, fruits, meat, fish, egg, chapathi, rice, total Calories24 h dietary recallIncidence and progressionDilated fundus examination using slit-lamp biomicroscopy (90D), indirect ophthalmoscopy, fundus photographyNot stated7
Yan et al., 2019
n = 8122
Not stated57.2 (5.2)Meat, dairy products, wholemeal bread, breakfast cereal, vegetables, fruit, and fruit juiceSelf-administered questionnaireIncidence and progressionRetinal photocoagulation from the Medicare Benefits Schedule data (note: used as a proxy for DR progression)Not stated6
29 Cross-Sectional Studies
Fenwick et al., 2015
n = 395
T2DM>18AlcoholValidated food frequency questionnairePrevalenceNon-dilated fundus photographyETDRS10
Ganesan et al., 2012
n = 1261
Any diabetes>40Dietary fiberValidated fiber
questionnaire
PrevalenceDilated fundus photographModified ETDRS10
Beulens et al., 2008
n = 1857
T1DM15–60AlcoholSelf-report in a general questionnairePrevalenceDilated fundus photographNone, Background, Proliferative10
Lee et al., 2022
DR: 270
no DR: 1080
T2DMDR: 59.9(0.8)
no DR: 58.6(0.4)
CoffeeValidated food frequency questionnairePrevalenceFundus photographETDRS, modified Airlie House Classification9
Liu et al., 2021
DR: 378
no DR: 894
Not stated>40Choline24 h dietary recallPrevalenceFundus photographNot stated9
Millen et al., 2016
n = 1305
Any diabetes45–65Vitamin D, fish, milkValidated food frequency questionnairePrevalenceFundus photographModified Airlie House Classification9
Sahli et al., 2016
n = 1430
Any diabetes45–65Carotenoids (lutein)Validated food frequency questionnairePrevalenceNon-dilated fundus photographETDRS9
Mayer-Davis et al., 1998
n = 387
T2DM20–74Vitamin C, Vitamin E, beta-carotene24 h dietary recallPrevalenceDilated fundus photographModified Airlie House Classification9
Moss et al., 1992
Young: 891
Older: 987
Any diabetes2–96AlcoholSelf-report in a general questionnairePrevalenceFundus photographModified Airlie House Classification9
Chen et al., 2022
DR: 696
no DR: 4515
Not statedDR: 62.43 (11.79)
no DR: 58.961 (12.421)
Calcium and potassium24 h dietary recallPrevalenceFundus photographETDRS8
She et al., 2020
DR: 119
No DR: 336
T2DMDR: 63.2 (8.5)
no DR: 65.4 (8.8)
Antioxidants3-day food recordPrevalenceFundus photographETDRS8
Chua et al., 2018
n = 357
T2DM58 (52–62)FishValidated food frequency questionnairePrevalenceTwo-field digital retinal photographsETDRS, Airlie House Classification8
Fenwick et al., 2018
n = 609
T1DM or T2DM64.6(11.6)Diet soft drinkValidated food frequency questionnairePrevalenceTwo-field (macula and optic disc) dilated fundus photos were captured using a non-mydriatic retinal camera (fundus photography)ETDRS for DR and the American Academy of Ophthalmology Scale for DME8
Granado-Casas et al., 2018
DR: 103
no DR: 140
T1DMDR: 46.2(10.8)
no DR: 42.1(10.3)
FatValidated food frequency questionnairePrevalenceOphthalmologist examinationInternational Clinical Classification System for diabetic retinopathy8
Thapa et al., 2018
DM: 1692
no DM: 168
Not statedDM: 69.8 (7.4)
no DM: 67.9 (6.7)
AlcoholSimple background questionnairePrevalenceDilated fundus examination by a retina specialistETDRS8
Sasaki et al., 2015
n = 379
Any diabetes>18Vitamin C, Vitamin E, beta-carotene, MUFA, PUFA, carbohydrates, proteinValidated food frequency questionnairePrevalenceFundus photographModified ETDRS8
Kumari et al., 2014
n = 353
Any diabetes21–95CoffeeQuestionnaire on coffee consumptionPrevalenceDilated fundus photographModified Airlie House Classification8
Mahoney et al., 2014
n = 155
Any diabetes>40Fruits and vegetablesValidated food frequency questionnairePrevalenceNon-dilated fundus photographETDRS8
Harjutsalo et al., 2013
n = 3608
T1DMMedian age: 37.4 (28.9–46.8)AlcoholSelf-report in a general questionnairePrevalenceHistory of laser photocoagulationSevere DR vs. None8
Millen et al., 2004
n = 1353
Any diabetes45–65Vitamin C and Vitamin EValidated food frequency questionnairePrevalenceNon-dilated fundus photographModified Airlie House Classification8
Xu et al., 2020
DM: 614
no DM: 4667
Not statedDM: 68.03(6.49)
no DM: 67.88(6.64)
TeaQuestionnaire on tea consumptionPrevalenceFundus photographETDRS7
Engelen et al., 2014
n = 1880
T1DM15–60SodiumEstimated from urinary sodium excretionPrevalenceFundus photographNone, NPDR, PDR7
Shalini et al., 2021
DR: 194
no DR: 150
Control: 151
T2DMDR: 55.0(0.6)
no DR: 56.0(0.9)
Control: 54.0(0.9)
CarotenoidsValidated raw food-based food frequency questionnaire with HPLC of plasma carotenoidsPrevalenceFundus examination by indirect ophthalmoscopy, slit-lamp biomicroscopy, fundus fluorescein angiographyETDRS6
Alsbirk et al., 2021
T1DM: 50
T2DM: 460
T1DM or T2DMT1DM: 44.5 (13–87)
T2DM: 66 (27–92)
Fish food, PUFAs supplementsQuestionnaire of self-reported dietary historyPrevalenceFundus photographInternational Clinical Diabetic Retinopathy, DME Severity Scale6
Mirghani et al., 2021
DR: 66
no DR: 134
Not stated50.74(13.51)Diet sugar-free carbonated soda beverageValidated food frequency questionnairePrevalenceFundus examinationNot stated5
Kawasaki et al., 2018
NPDR: 83
no NPDR: 280
T1DM or T2DMNPDR: 58.9
no NPDR: 55.6
AlcoholSimple background questionnairePrevalenceFundus findings from clinic and hospital recordsInternational Clinical Diabetic Retinopathy5
Lugo-Radillo et al., 2013
n = 88
Any diabetesNo DR: 58.50 (1.11)
DR: 56.82 (1.65)
Fruits and vegetablesOral questionnaire on fruit and vegetable consumptionPrevalenceOphthalmologist examinationInternational Classification System5
Roy et al., 1989
n = 34
Any diabetesDR: 37.9 (12)
No DR: 37.7 (9)
MUFA, PUFA, carbohydrates, protein, dietary fiber3-day food recordPrevalenceFundus photographyModified Airlie House Classification5
Acan et al., 2018
DME: 63
no DME: 350
T1DM or T2DMDME: 58.86 (11.27)
no DME: 56.03 (11.95)
AlcoholSimple background questionnairePrevalenceDilated fundoscopy by ophthalmologists, central macular thickness analysis with OCTETDRS, OCT central macular thickness ≥ 250 μm3
5 Case–control Studies
Alcubierre et al., 2016
Case: 146
Control:148
T2DM40–75MUFA, PUFA, oleic acid, carbohydrates, protein, dietary fiberValidated food frequency questionnairePrevalenceOphthalmologist examinationInternational Classification System10
Zhang et al., 2019
DM with DR: 43
DM without DR: 43
Controls: 40
T2DMDM with DR: 59 (49–66)
DM without DR: 53 (44–65)
Controls: 54(47–67)
Vitamin AValidated food frequency questionnaire with HPLC of plasma retinolPrevalenceNot statedNot stated8
Alcubierre et al., 2015
Case: 139
Control:144
T2DMNo DR: 58.1 (10.3)
DR: 60.3 (8.9)
Vitamin D, calciumValidated food frequency questionnairePrevalenceOphthalmologist examinationInternational Classification System8
Ma et al., 2014
Case:100
Control:100
T2DM>18Green teaQuestionnaire on tea consumptionPrevalenceFundus photographETDRS8
Giuffre et al., 2004
Case:45
Control:87
Any diabetes>40AlcoholSelf-report in a general questionnairePrevalenceDirect ophthalmoscopy and fundus photographETDRS7
DR—Diabetic retinopathy, DME—Diabetic macular edema, ETDRS—Early treatment diabetic retinopathy study, HPLC—High-performance liquid chromatography, MD—Mediterranean diet, MUFA—Monounsaturated fatty acid, NPDR—Non-proliferative diabetic retinopathy, OCT—Optical coherence tomography, PDR—Proliferative diabetic retinopathy, PRP—Pan retinal photocoagulation, PUFA—polyunsaturated fatty acid, DM—Diabetes Mellitus.
Table 2. Dietary intake of micronutrients and diabetic retinopathy.
Table 2. Dietary intake of micronutrients and diabetic retinopathy.
Study, Year
Study Design
Sample Size (n)
Quality
Score
Dietary Factor
and Its Association with DR
Adjustment/MatchedStatistical Method AnalysisKey Findings
Antioxidants
Carotenoids
Tanaka et al., 2013
Prospective
n = 978
10Carotenoids
Protective
Sex, age, BMI, HbA1c,
diabetes duration, insulin treatment, oral hypoglycaemic agents without insulin treatment, systolic blood pressure, LDL and HDL cholesterol, triglycerides, physical activity alcohol, smoking, total energy intake, proportions of dietary protein, fat, carbohydrate, saturated fatty acids, omega-6 PUFA and omega-3 PUFA and sodium
Multivariate Cox regressionHighest intake
Q4 vs. lowest Intake Q1, HR: 0.52 (0.33–0.81) p < 0.01
Sahli et al., 2016
Cross-sectional
n = 1430
9Lutein carotenoids
NS
Diabetes duration, HbA1c, blood pressure, race, total energy consumption, and study centerMultivariable logistic regressionIntake Q4 vs. Q1, OR: 0.89 (0.31–2.50), p = 0.72
Mayer-Davis et al., 1998
Cross-sectional
n = 387
9Beta-Carotene
NS
Age, gender, ethnicity, diabetes duration, HbA1c, hypertension, caloric intake, and insulin useMultivariable logistic regressionNo significant
associations with
DR (data not
shown)
Zhang et al., 2019
Case–control
Type2 DM-86
control-40
8Retinol carotenoids
Protective
Age, sex, smoking, BMI and alcohol consumptionLogistic regressionIntake of retinol (100 μg/day) on DR (OR: 0.88, 95%CI, 0.79–0.98, p = 0.025)
Sasaki et al., 2015
Cross-sectional
n = 379
8Beta-carotene
NS
Intake of energyData not shownNo significant associations with
DR (data not shown)
Shalini et al., 2021
Cross-sectional
n = 495
7Carotenoids
Protective
NilOne-way analysis of variance F test with a post hoc test of least significant differenceThe plasma concentration of carotenoids was significantly lower in the DR group compared to no DR patients and healthy controls (p < 0.001)
Vitamin C
Tanaka et al., 2013
Prospective
n = 978
10Vitamin C
Protective
Sex, age, BMI, HbA1c,
diabetes duration, insulin treatment, oral hypoglycaemic agents without insulin treatment, systolic blood pressure, LDL and HDL cholesterol, triglycerides, physical activity alcohol, smoking, total energy intake, proportions of dietary protein, fat, carbohydrate, saturated fatty acids, omega-6 PUFA and omega-3 PUFA and sodium
Multivariate Cox regressionIntake Q4 vs. Q1,
HR: 0.61 (0.39–0.96), p = 0.03
Mayer-Davis et al., 1998
Cross-sectional
N = 387
9Vitamin C
Risk
Age, gender, ethnicity, diabetes duration, HbA1c, hypertension, caloric intake, and insulin useMultivariable
logistic
regression
Intake 9th decile vs. 1st quintile,
OR: 2.21, (p = 0.01)
She et al., 2020
Cross-sectional
n = 455
8Vitamin C
NS
Sex, race, insulin use, HbA1c, hypertension, exerciseBinomial logistic regression multivariate analysisNo significant association with DR (p = 0.413)
Sasaki et al., 2015
Cross-sectional
n = 379
8Vitamin C
NS
Intake of energyData notshownNo significant association with DR (data not shown)
Millen et al., 2004
Cross-sectional
n = 1353
8Vitamin C
NS
Race, BMI, diabetes duration, serum glucose, total energy intake, hypertension, waist–hip ratio, smoking, alcohol, drinking status, plasma cholesterol, hematocrit value, prevalent coronary heart disease, plasma triacylglycerol, diabetes treatment group, and oral hypoglycaemic treatment or insulin treatmentMultivariable logistic regressionIntake Q4 vs. Q1, OR: 1.4 (0.8–2.4),
p = 0.19
Vitamin E
Tanaka et al., 2013
Prospective
n = 978
10Vitamin E
NS
Sex, age, BMI, HbA1c,
diabetes duration, insulin treatment, oral hypoglycaemic agents without insulin treatment, systolic blood pressure, LDL and HDL cholesterol, triglycerides, physical activity alcohol, smoking, total energy intake, proportions of dietary protein, fat, carbohydrate, saturated fatty acids, omega-6 PUFA and omega-3 PUFA and sodium
Multivariate Cox regressionIntake Q4 vs. Q1, HR: 0.84 (0.51–1.40), p = 0.51
Mayer-Davis et al., 1998
Cross-sectional
N = 387
9Vitamin E
Risk (in non-insulin taking subjects)
Age, gender, ethnicity, diabetes duration, HbA1c, hypertension, caloric intake, and insulin useMultivariable logistic regressionNo association found in insulin subjects and in non-insulin
taking subjects: Intake 10th decile vs. 1st quintile, OR: 3.79, (p < 0.02)
She et al., 2020
Cross-sectional
n = 455
8Vitamin E
Protective
Sex, race, insulin use, HbA1c, hypertension, exerciseBinomial logistic regression multivariate analysisIntake in DR vs. No DR
(OR: 0.97, 95%CI: 0.95–1.00, p = 0.036)
Granado-Casas et al., 2018
Cross-sectional
n = 243
8Vitamin E
Protective
Age, sex, educational level, smoking, physical activity, BMI, dyslipidemia, hypertension, diabetes duration, HbA1cMultivariable conditional logistic regression modelsIntake of Vitamin E on DR
(OR: 0.85 [0.77–0.95], p = 0.006)
Sasaki et al., 2015
Cross-sectional
n = 379
8Vitamin E
NS
Intake of energyData notshownNo significant associations with DR (data not shown)
Millen et al., 2004
Cross-sectional
n = 1353
8Vitamin E
NS
Race, BMI, diabetes duration, serum glucose, total energy intake, hypertension, waist–hip ratio, smoking, alcohol, drinking status, plasma cholesterol, hematocrit value, prevalent coronary heart disease, plasma triacylglycerol, diabetes treatment group, and oral hypoglycaemic treatment or insulin treatmentMultivariable logistic regressionIntake Q4 vs. Q1, OR: 1.4 (0.8–2.3), p = 0.76
Selenium
She et al., 2020
Cross-sectional
n = 455
8Selenium
Protective
Sex, race, insulin use, HbA1c, hypertension, exerciseBinomial logistic regression multivariate analysisIntake in DR vs. No DR (OR: 0.98, 95%CI: 0.96–1.00, p = 0.017)
Riboflavin
She et al., 2020
Cross-sectional
n = 455
8Riboflavin
NS
Sex, race, insulin use, HbA1c, hypertension, exerciseBinomial logistic regression multivariate analysisNo significant association with DR (p > 0.05)
Vitamin D
Millen et al., 2016
Cross-sectional
n = 1305
9Vitamin D
NS
Race, duration of diabetes,
HbA1c and, hypertension
Multivariable logistic regressionIntake Q4 vs. Q1, OR: 1.20 (0.76–1.89), p trend = 0.740
Alcubierre et al., 2015
Case–control
Case:139 Ctrl:144
8Vitamin D
NS
NILChi-squaredNo significant
associations with DR (p = 0.93)
Choline
Liu et al., 2021
Cross-sectional
n = 1272
9Choline
Risk in female
Age, race, diabetes duration, glycaemic control, CVD, CKD * results analyzed in individual sex groupsMultivariable logistic regressionHigh intake vs. low intake (OR: 2.14, 95%CI: 1.38–3.31; p = 0.001)
Calcium
Chen et al., 2022
Cross-sectional
n = 5321
9Calcium
Protective
Age, sex, race, smoking, serum glucose, serum laboratory data, hemoglobinMultivariable logistic regressionHigh intake vs. low intake OR: 0.70, 95%CI: 0.54–0.90, p = 0.05)
Alcubierre et al., 2015
Case–control
Case:139 Ctrl:144
8Calcium
NS
NILChi-squaredNo significant
associations with DR (p = 0.65)
Potassium
Tanaka et al., 2013
Prospective
n = 978
10Potassium
NS
Sex, age, BMI, HbA1c,
diabetes duration, insulin treatment, oral hypoglycaemic agents without insulin treatment, systolic blood pressure, LDL and HDL cholesterol, triglycerides, physical activity alcohol, smoking, total energy intake, proportions of dietary protein, fat, carbohydrate, saturated fatty acids, omega-6 PUFA and omega-3 PUFA and sodium
Multivariate Cox regressionNo significant association with DR (p > 0.05)
Chen et al., 2022
Cross-sectional
n = 5321
9Potassium
Protective
Age, sex, race, smoking serum glucose, serum laboratory data, hemoglobinMultivariable logistic regressionHigh intake vs. low intake OR: 0.761, 95%CI: 0.59–0.97, p = 0.029
Sodium
Horikawa et al., 2021
Prospective
n = 912
10Sodium
Risk (under low vegetable consumption)
Age, sex, BMI, HbA1c,
diabetes duration, LDL cholesterol, HDL cholesterol, log-transformed triglycerides, insulin treatment, smoking, alcohol, energy intake, physical activity, systolic blood pressure, angiotensin II receptor blocker, angiotensin-converting enzyme inhibitor, calcium channel blocker
Multivariate Cox regression analysesIntake for 2nd, 3rd, and 4th quartile vs. 1st quartile, HRs were 0.87 [95%CI, 0.31–2.41], 2.61 [1.00–6.83], and 3.70 [1.37–10.02], respectively
p = 0.010.
Horikawa et al., 2014
Prospective
n = 978
10Sodium
NS
Sex, age, BMI, HbA1c,
duration of diabetes, LDL
cholesterol, HDL cholesterol,
log-transformed triglycerides, insulin treatment, lipid-lowering agents, smoking, alcohol intake, energy intake, sodium intake, and physical activity
Multivariate Cox regressionIntake Q4 vs. Q1, HR: 1.10 (0.75–1.61), p = 0.55
Roy et al., 2010
Prospective
n = 469
10Sodium
Risk (ForDME)
NS for DR
Age, sex, HbA1c, hypertension, total caloric intake, protein intake, oleic acid intake, physical exercise, and oleic acid intakeMultivariable logistic regressionIntake Q4 vs. Q1, OR: 1.43 (1.10–1.86), p = 0.008 for DME.
No significant
associations with DR
Cundiff et al., 2005
Prospective
n = 1412
8Sodium
NS
Intake of energySpearman correlationSodium in mg/kcal against DR progression rate, r = 0.02 (p = 0.47)
Engelen et al., 2014
Cross-sectional
n = 1880
7Sodium
NS
Sex, age, smoking, BMI,
urinary potassium excretion, sat fat intake, protein intake antihypertensive medication, total energy intake, physical activity, fiber intake, and alcohol intake
Multivariable logistic regressionPer 1g/day increase in dietary salt intake against NPDR OR: 1.00, (0.96–1.04, p = 0.84.
PDR OR:
1.02 (0.95–1.08), p = 0.65
Vitamin B6
Horikawa et al., 2019
Prospective
n = 978
9Vitamin B6
Protective
Age, sex, BMI, HbA1c, diabetes duration, systolic blood pressure, LDL cholesterol, HDL cholesterol, triglycerides, insulin treatment, oral hypoglycemic agents, antihypertensive agents, lipid-lowering agents, urine albumin creatinine ratio, estimated glomerular filtration rate, alcohol, smoking, energy intake, physical activity, retinol, vitamin B1, vitamin B2, vitamin B9, vitamin B12Multivariate Cox regression analysesIntake Q4 vs. Q1 HR: 0.50, 95%CI: 0.30–0.85,
p = 0.010)
BMI—Body mass index, CI–Confidence interval, CVD—Cardiovascular disease, CKD—Chronic kidney disease, CI—Confidence interval, DR—Diabetic retinopathy, DME—diabetic macular edema, DM—Diabetes mellitus, HDL—High-density lipoprotein, HR—Hazard ratio, HbA1c—glycated hemoglobin, LDL—Low-density lipoprotein, NS—Not significant, NPDR—Non-proliferative diabetic retinopathy, OR—Odds ratio, PUFA—Polyunsaturated fatty acid, PDR—Proliferative diabetic retinopathy.
Table 3. Dietary intake of macronutrients and diabetic retinopathy.
Table 3. Dietary intake of macronutrients and diabetic retinopathy.
Study, Year
Study Design
Sample Size (n)
Quality
Score
Dietary Factor
and Its Association with DR
Adjustment/MatchedStatistical Methods AnalysisKey Findings
Dietary Fats/lipids
Monounsaturated Fatty Acids (MUFA)
Alcubierre et al.,2016
Case–control
Case:146 Ctrl:148
10MUFA
Protective
Sex, age, diabetes
duration, energy intake, systolic blood pressure,
physical activity, waist circumference, HDL cholesterol, educational level and diabetes treatment
Multivariable logistic regressionHigh MUFA
consumption vs. low MUFA consumption, OR: 0.42 (0.18–0.97), p = 0.034
Sasaki et al., 2015
Cross-sectional
n = 379
10MUFA
NS
Sex, Age, HbA1c, duration of diabetes, and mean arterial pressureMultivariable logistic regression modelsPer 10 energy-adjusted
g/d increase, OR: 1.19
(0.74–1.92)
Roy et al., 2010
Prospective
n = 469
9MUFA
NS
Total fat, total caloric intake, oleic acid, linoleic acid, fiber, protein, sat fat, cholesterol and sodium intakesMultivariable logistic regressionNo significant
associations with DR (data not shown)
Granado-Casas et al., 2018
Cross-sectional
n = 243
8MUFA
Protective
Age, sex, educational level, smoking, center, physical activity, BMI, dyslipidemia
hypertension, diabetes duration, HbA1c
Multivariable conditional logistic regression modelsMUFA intake against frequency of DR (OR: 0.95, 95%CI: 0.92–0.99, p = 0.012)
Cundiff et al., 2005
Prospective
n = 1412
8MUFA
Risk
Intake of energy SpearmancorrelationMUFA in %/kcal against DR progression rate, r = 0.12 (p = 0.001)
Roy et al., 1989
Cross-sectional
n = 34
5MUFA
NS
Intake of energyt testNo significant associations with DR (data not shown)
Oleic acid
Alcubierre et al., 2016
Case–control
Case:146 Ctrl:148
10Oleic acid
Protective
Sex, age, diabetes
duration, energy intake, systolic blood pressure,
physical activity, waist circumference, HDL cholesterol, educational level and diabetes treatment
Multivariable logistic regressionHighest intake tertile (T3) vs. lowest intake tertile (T1), OR: 0.37 (0.16–0.85), p = 0.017
Roy et al., 2010
Prospective
n = 469
9Oleic acid
NS
Total fat, total caloric intake, oleic acid, linoleic acid, fiber, protein, sat fat, cholesterol and sodium intakeMultivariable logistic regressionNo significant
associations with DR (data not reported)
Granado-Casas et al., 2018
Cross-sectional
n = 243
8Oleic acid
Protective
Age, sex, educational level, smoking, center, physical activity, BMI, dyslipidemia
hypertension, diabetes duration, HbA1c
Multivariable conditional logistic regression modelsOleic acid intake against DR (OR: 0.95, CI: 0.92–0.99, p = 0.012)
Polyunsaturated Fatty Acids (PUFA)
Alcubierre et al., 2016
Case–control
Case:146 Ctrl:148
10PUFA
NS
Sex, age, diabetes
duration, energy intake, systolic blood pressure,
physical activity, waist circumference, HDL cholesterol, educational level and diabetes treatment
Multivariable logistic regressionHigh PUFA
consumption vs. low MUFA
consumption, OR: 0.99 (0.69–1.41)
Sasaki et al., 2015
Cross-sectional
n = 379
10PUFA
Protective forwell controlleddiabetics
Sex, age, HbA1c, duration of diabetes, and mean arterial pressureMultivariablelogistic regression modelsAll subjects:
Per 10 energy-adjusted g/d increase,
OR: 0.67 (0.37–1.20)
Well-controlled diabetics:
Per 10 energy adjusted g/d increase,
OR: 0.18 (0.06–0.59)
Sala-Vila et al., 2016
Prospective
n = 3482
9PUFA (long-chain omega-3 fatty acid)
Protective
Age, sex, BMI,
intervention group, duration of diabetes, insulin treatment, oral hypoglycemic treatment, smoking, hypertension, systolic blood pressure, physical activity, and adherence to the Mediterranean diet
Cox proportional hazard model>500 mg/d vs.
<500 mg/d, HR: 0.52 (0.31–0.88)
p = 0.001
Roy et al., 2010
Prospective
n = 469
9PUFA
NS
Total fat, total caloric intake, oleic acid, linoleic acid, fiber, protein, sat fat, cholesterol and sodium intakesMultivariable logistic regressionNo significant
associations with DR (data not shown)
Cundiff et al., 2005
Prospective
n = 1412
8PUFA
Risk
Intake of energySpearman correlationPUFA in %/kcal
against DR
progression rate,
r = 0.09 (p = 0.004)
Roy et al., 1989
cross-sectional
5PUFA
NS
Intake of energyt testNo significant
associations with DR (data not reported)
Interventional studies
Howard-Williams et al., 1985
Interventional
n = 149
HighBiasPUFA
NS
Age, sex and
BMI
Participants on a modified fat diet (PUFA: saturated fat ratio, 0.3) vs.
low-carb diet (PUFA: saturated fat ratio, 0.9)
No difference between the two groups in all participants (n = 149) (chi-squared, p = 0.69)
No difference between the two groups in dietary compliers (n = 58) (chi-squared, p = 0.13)
Houtsmuller et al., 1979
Interventional
n = 96
HighbiasUnsaturatedfats
Protective
GenderSaturated fat diet vs. unsaturated fat diet
males (n = 52, 26 on each diet) p < 0.001
females (n = 44, 22 on each diet) p < 0.025
Carbohydrates
Horikawa et al., 2017
Prospective
n = 936
10Carbohydrates
NS
Gender, age, BMI, HbA1c,
diabetes duration, insulin treatment, systolic blood pressure, LDL cholesterol, HDL cholesterol, antihypertensive agents, lipids lowering drugs, energy intake, triglycerides, current smoker, alcohol consumption, and physical activity
Multivariable Cox regression modelsHighest intake
tertile (T3) vs.
lowest intake
tertile (T1), HR:
1.00 (0.72–1.38)
Alcubierre et al., 2016
Case–control
Case:146 Ctrl:148
10Carbohydrates
NS
Sex, age, diabetes
duration, energy intake, systolic blood pressure,
physical activity, waist circumference, HDL cholesterol, educational level and diabetes treatment
Multivariable logistic regressionHighest intake tertile (T3) vs. lowest
intake tertile (T1), OR: 1.18 (0.45–3.09)
Roy et al., 2010
Prospective
n = 469
9Carbohydrates
NS
Total fat, total caloric intake, oleic acid, linoleic acid, fiber, protein, sat fat, cholesterol, and sodium intakesMultivariable logistic regressionNo significant
associations with DR (data not shown)
Granado-Casas et al., 2018
Cross-sectional
n = 243
8Carbohydrates
Risk
Age, sex, educational level
smoking, center, physical activity, BMI, dyslipidemia
hypertension, diabetes duration, HbA1c
Multivariable conditional logistic regression modelsIntake of complex carbohydrates against DR (OR: 1.02, CI: 1.00–1.04, p = 0.031)
Sasaki et al., 2015
Cross-sectional
n = 379
8Carbohydrates
NS
Intake of energyChi-squaredNo significant
associations with DR (data not shown)
Cundiff et al., 2005
Prospective
n = 1412
8Carbohydrates
Protective
Intake of energySpearman
correlation
Carbohydrates in %/kcal against DR progression rate, r = −0.11 (p < 0.001)
Roy et al., 1989
cross-sectional
n = 34
5Carbohydrates
Protective
Intake of energyt testPersons without
retinopathy vs.
persons with
retinopathy
(p < 0.05)
Protein
Park et al., 2021
Prospective
n = 2067
10Protein (glutamic acid and aspartic acid)
NS for DR
incidence, however aspartic acid protective for PDR
Age, sex, HbA1c, diabetes duration, education
income, occupation, creatinine clearance,
alanine aminotransferase, other comorbidities
Cox proportional hazard modelsNo significant association with DR incidence.
Intake of aspartic acid highest tertile vs. lowest tertile for PDR (HR: 0.39, 95%CI: 0.16–0.96, p = 0.013)
Alcubierre et al., 2016
Case–control
Case:146 Ctrl:148
10Protein
NS
Sex, age, diabetes
duration, energy intake, systolic blood pressure,
physical activity, waist circumference, HDL cholesterol, educational level and diabetes treatment
Multivariable logistic regressionHighest protein intake tertile (T3) vs lowest protein intake tertile (T1),
OR: 1.24 (0.49–3.16)
Roy et al., 2010
Prospective
n = 469
9Protein
NS
Total fat, total caloric intake, oleic acid, linoleic acid, fiber, protein, sat fat, cholesterol, and sodium intakes Multivariable logistic regressionNo significant
associations with DR (data not shown)
Sasaki et al., 2015
Cross-sectional
n = 379
8Protein
NS
Intake of energyChi-squaredNo significant
associations with DR (data not shown)
Cundiff et al., 2005
Prospective
n = 1412
8Protein
Protective
Intake of energySpearman correlationProtein in %/kcal against DR progression rate, r = −0.6 (p = 0.018)
Roy et al., 1989
Cross-sectional
n = 34
5Protein
Risk
Intake of energyt testPersons without retinopathy vs. persons with retinopathy (p < 0.02)
CI—confidence interval, DME—Diabetic macular edema, DR—Diabetic retinopathy, HR—Hazard ratio, HbA1c—glycated hemoglobin, HDL—High-density lipoprotein, LDL—Low-density lipoprotein, MUFA—Monounsaturated fatty acid, NS—No significance, NPDR—Non-proliferative diabetic retinopathy, OR—Odds ratio, PDR—Proliferative diabetic retinopathy, PUFA—Polyunsaturated fatty acid.
Table 4. Dietary intake of foods and diabetic retinopathy.
Table 4. Dietary intake of foods and diabetic retinopathy.
Study, Year
Study Design
Sample Size (n)
Quality scoreDietary Factor
and Its Association with DR
Adjustment/MatchedStatistical Methods AnalysisKey Findings
Fruits, vegetables, and dietary fiber
Alcubierre et al., 2016
Case–control
Case:146 Ctrl:148
10Dietary fiber
NS
Sex, age, diabetes
duration, energy intake, systolic blood pressure,
physical activity, waist circumference, HDL cholesterol, educational level and diabetes treatment
Multivariable logistic regressionHighest fiber intake tertile (T3) vs. lowest fiber intake tertile (T1), OR: 0.76 (0.33–0.76)
Tanaka et al., 2013
Prospective
n = 978
10Fruits, vegetables, and dietary fiber
Protective
Sex, age, BMI, HbA1c,
diabetes duration, insulin treatment, oral hypoglycaemic agents without insulin treatment, systolic blood pressure, LDL and HDL cholesterol, triglycerides, physical activity alcohol, smoking, total energy intake, proportions of dietary protein, fat, carbohydrate, saturated fatty acids, omega-6 PUFA and omega-3 PUFA and sodium
Multivariate Cox regressionVeg and fruit intake Q4 vs. Q1, HR: 0.59 (0.37–0.92), p < 0.01. Fruit intake Q4 vs. Q1, HR: 0.48(0.32–0.71), p = 0.01.
Dietary fiber intake Q4 vs. Q1, HR: 0.63 (0.38–1.03), p = 0.07.
Ganesan et al., 2012
Cross-sectional
n = 1261
10Dietary fiber
Protective
Sex, Age, diabetes duration, blood pressure, BMI,
Hba1c, serum lipids, smoking, and, socioeconomic status.
Multivariable logistic regressionLow-fiber diet vs. healthy fiber diet for any DR, OR: 1.41 (1.02–1.94), p = 0.039.
Low-fiber diet vs. healthy fiber diet for VTDR, OR: 2.24 (1.01–5.02), p = 0.049.
Roy et al., 2010
Prospective
n = 469
9Dietary fiber
NS
Total fat, total caloric intake, oleic acid, linoleic acid, fiber, protein, sat fat, cholesterol, and sodium intakesMultivariable logistic regressionNo significant associations with DR
(Data not shown)
Cundiff et al., 2005
Prospective
n = 1412
8Dietary fiber
Protective
Intake of energySpearman correlationDietary fiber in g/1000kcal against DR progression rate, r = −0.10 (p = 0.002)
Yan et al., 2019
Prospective
n = 8122
6Fruits,
vegetables, and dietary fiber
NS
Age, sex, income, educational level, BMI, hypertension, CVD, family history of diabetes,
insulin treatment
Cox regression model.No significant
associations with DR (p < 0.05)
Roy et al., 1989
Cross-sectional
n = 34
5Dietary fiber
Protective
Diabetes durationt testPersons without retinopathy vs. persons
with retinopathy, (p < 0.01)
Rice
Kadri et al., 2021
Prospective
n = 261
8Rice
Risk
Age, sex, duration, antioxidants, pharmacological treatment, egg, fish, chapathi, riceMultivariate regression analysisRice consumption yes vs. no, OR: 3.19, 95%CI: 1.17–8.69, p = 0.018
Cheese and wholemeal bread
Yan et al., 2019
Prospective
n = 8122
6Cheese and wholemeal bread
Protective
Age, sex, income, educational level, BMI, hypertension, CVD, family history of diabetes,
insulin treatment
Cox regression model.Cheese intake highest quartiles vs. lowest HR: 0.58, 95%CI: 0.41–0.83, p = 0.007 and wholemeal bread HR: 0.64, CI: 0.4–0.89, p = 0.04
Fish
Sala-Vila et al., 2016
Prospective
n = 3482
9Oily fish
Protective
Age, sex, BMI,
intervention group, duration of diabetes, insulin treatment, oral hypoglycemic treatment, smoking, hypertension, systolic blood pressure,
physical activity, and adherence to the Mediterranean diet
Cox proportional hazard model>2 servings a week vs. <2 servings a week,
HR: 0.41 (0.23–0.72), p = 0.002
Kadri et al., 2021
Prospective
n = 261
8Fish
Protective
Age, sex, duration, antioxidants, pharmacological treatment, egg, fish, chapathi, riceMultivariate regression analysisFish intake, more frequent vs. less frequent, OR: 0.42, 95%CI: 0.18–0.94, p < 0.05
Chua et al., 2018
Cross-sectional
n = 357
8Fish
Protective
Age, sex, race, smoking diabetes duration, diabetic treatment, lipid-lowering medication use, systolic blood pressure, HbA1c, triglyceridesOrdered logistic and linear regression modelsPer one serving increase in fish intake per week, OR: 0.91, 95%CI: 0.84–0.99, p = 0.038
Yan et al., 2019
Prospective
n = 8122
6Fish
NS
Age, sex, income, educational level, BMI, hypertension, CVD,
family history of diabetes, Insulin treatment
Cox regression modelNo significant
associations with DR (p = 0.22)
Alsbirk et al., 2021
Cross-sectional
n = 510
6Fish oil
NS
Age, sex, diabetes type, diabetes duration, HbA1c, medicationLogistic regressionNo significant association (p > 0.005)
Other types of food
Yan et al., 2019
Prospective
n = 8122
6Processed meat/breakfast cereal
NS
Age, sex, income, educational level, BMI, hypertension, CVD,
family history of diabetes, insulin treatment
Cox regression model.No significant
associations with DR (p > 0.05)
BMI—Body mass index, CVD—Cardiovascular disease, DR—Diabetic retinopathy, HDL—High-density lipoprotein, HbA1c—Glycated hemoglobin, PUFA—Polyunsaturated fatty acid, VTDR—Vision-threatening diabetic retinopathy.
Table 5. Dietary intake of beverages, dietary patterns, and diabetic retinopathy.
Table 5. Dietary intake of beverages, dietary patterns, and diabetic retinopathy.
Study, Year
Study Design
Sample Size (n)
Quality
Score
Dietary Factor
and Its Association with DR
Adjustment/MatchedStatistical Methods AnalysisKey Findings
Coffee
Lee at al, 2022
Cross-sectional
n = 1350
9Coffee
Protective
Age, sex, education, income, BMI, energy intake, hypertension, dyslipidemia, diabetes duration, HbA1c, smoking, alcohol, physical activityMultivariable logistic regression modelsConsumption ≥ 2 cups coffee/day vs. none for DR (OR: 0.53, 95%CI: 0.28–0.99, p for trend = 0.025) and VTDR (OR: 0.30, 95%CI: 0.10–0.91, p for trend = 0.005)
Kumari et al., 2014
Cross-sectional
n = 353
9Coffee
NS
Sex, age, HbA1c, smoking, BMI, creatinine, education level, diabetes duration, family history of diabetes, hypertension, stroke, ischemic heart disease, dyslipidemia, and cancerMultivariable logistic regressionCoffee drinker vs.
never/rarely, OR: 1.36 (0.69–2.69)
Tea
Ma et al., 2014
Case–control
Case:100 Ctrl:100
8Green Tea
Protective
Diabetes duration, insulin treatment, family history of diabetes, fasting blood glucose, education, BMI, systolic blood pressure, smoking, alcohol, physical and, activityMultivariable logistic regressionRegular Chinese green tea drinker vs. non-regular Chinese green tea drinker, OR: 0.48, CI: 0.24–0.97, p = 0.04
Xu et al., 2020
Cross-sectional
n = 5,281
7Tea
Protective
Age, sex, individual monthly income, fasting blood glucose, systolic blood pressure, occupation, educational level, smoking, alcoholMultivariate logistic regression analysesTea consumers vs. non-tea consumers, OR: 0:29, 95%CI: 0.09–0.97, p = 0.04
Milk
Yan et al., 2019
Prospective
n = 8122
6Milk
NS
Age, sex, income,
educational level, BMI, hypertension,
CVD, family history of diabetes, insulin treatment
Cox regression modelNo significant
associations with DR (p = 0.74)
Diet soda
Fenwick et al., 2018
Cross-sectional
n = 609
8Diet soft drink
Risk
Age, sex, HbA1c, diabetes duration, insulin use, presence of at least one other diabetes complication, diabetes type, BMI, education
antihypertensive medication, hyperlipidaemia, presence of comorbidity, smoking, alcohol
energy intake, regular soft drink consumption
Multinomial logistic regressionHigh-consumption (>4 cans [1.5
liters]/week) vs. no consumption for proliferative DR (OR = 2.62, 95%CI = 1.14–6.06, p = 0.024)
Mirghani et al., 2021
Cross-sectional
n = 200
6Diet sugar-free carbonated soda beverage
Risk
NILMultiple regression analysisDiet soda was associated with DR (p = 0.043)
Alcohol
Fenwick et al., 2015
Cross-sectional
n = 395
10Alcohol
Protective
Sex, gender, poorly controlled diabetes, diabetes duration, BMI, smoking, systolic blood pressure, insulin therapy, and presence of at least one other diabetic complicationMultivariable logistic
regression
Moderate vs. abstainers, OR: 0.47 (0.26–0.85), p = 0.013;
moderate white wine vs. abstainers, OR: 0.48 (0.25–0.91), p = 0.024;
moderate fortified wine vs. abstainers, OR: 0.15 (0.04–0.62), p = 0.009
Beulens et al., 2008
Cross-sectional
n = 1857
10Alcohol
Protective
Sex, Age, smoking, center, smoking, diabetes duration, physical activity, presence of CVD, systolic blood pressure, BMI, and HbA1CMultivariable logistic
regression
Moderate vs. abstainers, OR: 0.60 (0.37–0.99),
p = 0.023
Lee et al., 2010
Prospective
n = 1239
9Alcohol
NS
Sex, age, ethnicity, smoking, HbA1c, BMI, systolic blood pressure, and duration diabetesMultivariable logistic regressionModerate vs. none, OR: 1.08 (0.70–1.67)
Heavy vs. none, OR: 1.07 (0.54–2.13), p = 0.8
Moss et al., 1993
Prospective
Younger: 439 Older: 478
9Alcohol
NS
Sex, age, HbA1cMultivariable logistic
regression
Younger-onset
diabetics per 1oz/day increase in alcohol consumption on DR incidence, OR: 2.09 (0.04–1.07);per 1oz/day increase in alcohol consumption
on DR progression,
OR: 1.25 (0.75–2.08).
Older-onset diabetics
per 1oz/day increase in alcohol consumption on DR incidence, OR: 0.75 (0.4–1.42); per 1oz/day increase in alcohol consumption
on DR progression,
OR: 0.73 (0.4–1.20)
Moss et al., 1992
Cross-sectional
Younger: 891 Older: 987
9Alcohol
Protective
Diabetes duration, age, HbA1c, diastolic blood pressure, insulin therapyMultivariable logistic
regression
Younger-onset
diabetes population
per 1oz/day increase in alcohol consumption
for PDR, OR: 0.49,
(0.27–0.92)
Older-onset: no
significant associations
Gupta et al., 2020
Prospective
n = 656
8Alcohol
Protective
Age, sex, BMI, smoking, systolic blood pressure, income, HbA1c, diabetes duration, hyperlipidaemia, CKD, antidiabetic medicationMultivariable analysesAlcohol consumption vs. non-drinkers, OR: 0.36 (0.13 to 0.98) p = 0.045; occasional drinker (≤2 days/week) vs. non-drinkers, OR:0.17, (0.04–0.69), p = 0.013)
Thapa et al., 2018
Cross-sectional
n = 1860
8Alcohol
Risk
NILMultivariable logistic regression analysisAlcohol consumption yes vs. no for DR (OR:4.3, 95%CI: 1.6–11.3, p = 0.004) and vision-threatening DR (OR: 8.6, 95%CI: 1.7–47.2, p = 0.010)
Harjutsalo et al., 2013
Cross-sectional
n = 3608
8Alcohol
Protective
Sex, diabetes duration, age at onset of diabetes,
triglycerides, HbA1C, HDL cholesterol, social class, BMI, smoking status, lipid-lowering agents and hypertension
Multivariable logistic regressionAbstainers vs. light consumers, OR:
1.42 (1.11–1.82), p < 0.05;
former users vs. light consumers,
OR: 1.73 (1.07–2.79), p < 0.05
Cundiff et al., 2005
Prospective
n = 1412
8Alcohol
NS
Intake of energySpearman correlationNo significant
association with DR
(p = 0.26)
Young et al., 1984
Prospective
n = 296
8Alcohol
Risk
Diabetes duration, impotence and glycemic controlMultivariable logistic
regression
Heavy consumption vs. none–moderate
consumption, RR: 2.25 (1.15–4.42)
Giuffre et al., 2004
Case–control
Case:45 Ctrl:87
7Alcohol
NS
Diabetes duration,
duration of oral treatment and duration of insulin therapy
Multivariable logistic
regression
No significant
association with DR
(data not shown)
Kawasaki et al., 2018
Cross-sectional
n = 363
5Alcohol
NS
Age, sex, HbA1c, diabetes duration, medication, BMI, lifetime maximum body weight, systolic blood pressure, diastolic blood pressure, non-HDL cholesterol, HDL-cholesterol, LDL, estimated glomerular filtration rate, history of myocardial infarction, history of stroke, alcohol, smoking, number of oral hypoglycemic agents, number of antihypertensive agentsMultiple logistic regression modelNo signification was seen (p = 0.759)
Acan et al., 2018
Cross-sectional
n = 413
3Alcohol
Risk
NILt testp = 0.010
Mediterranean Diet
Ghaemi et al., 2021
Prospective
n = 22187
7Mediterranean diet
Protective
Age, sex, time, HbA1c, fasting plasma glucose, HDL-cholesterol, total cholesterol, total triglycerides, systolic blood pressure, obesity, smoking, diabetes durationPooled logistic regression modelsMediterranean diet against incident retinopathy in type 1 DM (OR: 0.32, 95%CI: 0.24–0.44, p = <0.001) and type 2 DM (OR: 0.68, 95%CI: 0.61–0.71, p = <0.001)
Diaz-Lopez et al., 2015
Interventional
n = 3614
ModerateBiasMediterranean diet
Protective
Sex, age, waist circumference, BMI, smoking, physical activity, hypertension, educational
level, dyslipidemia, family history of premature coronary heart disease, and baseline adherence
Multivariate Cox regressionMediterranean diet vs. control diet, HR: 0.60 (0.37–0.96)
Caloric Intake
Alcubierre et al., 2016
Case–control
Case:146 Control:148
10Caloric intake
NS
Sex, age, diabetes
duration, energy intake, systolic blood pressure,
physical activity, waist circumference, HDL cholesterol, educational level and diabetes treatment
Multivariable logistic regressionHighest energy intake tertile (T3) vs. lowest energy intake tertile (T1), OR: 0.73 (0.37–1.46)
Roy et al., 2010
Prospective
n = 469
10Caloric intake
Risk
Sex, age, total caloric intake, oleic acid intake, physical exercise, glycated hemoglobin, carbohydrate intake, protein intake, and hypertensionMultivariable logistic regressionHigher caloric intake,
OR: 1.48 (1.15–1.92), p = 0.003
Cundiff et al., 2005
Prospective
n = 1412
8Caloric intake
Risk
NILSpearman correlationCalories in kcal against DR progression rate,
r = 0.07 (p = 0.007)
BMI—Body mass index, CVD—Cardiovascular disease, CKD—Chronic kidney disease, DM—Diabetes Mellitus, DR—Diabetic retinopathy, HDL—High-density lipoprotein, HbA1c—Glycated hemoglobin, LDL—Low-density lipoprotein, OR—Odds ratio, PDR—Proliferative diabetic retinopathy, RR—Relative risk, VTDR—Vision-threatening diabetic retinopathy.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Shah, J.; Cheong, Z.Y.; Tan, B.; Wong, D.; Liu, X.; Chua, J. Dietary Intake and Diabetic Retinopathy: A Systematic Review of the Literature. Nutrients 2022, 14, 5021. https://doi.org/10.3390/nu14235021

AMA Style

Shah J, Cheong ZY, Tan B, Wong D, Liu X, Chua J. Dietary Intake and Diabetic Retinopathy: A Systematic Review of the Literature. Nutrients. 2022; 14(23):5021. https://doi.org/10.3390/nu14235021

Chicago/Turabian Style

Shah, Janika, Zi Yu Cheong, Bingyao Tan, Damon Wong, Xinyu Liu, and Jacqueline Chua. 2022. "Dietary Intake and Diabetic Retinopathy: A Systematic Review of the Literature" Nutrients 14, no. 23: 5021. https://doi.org/10.3390/nu14235021

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop